| ||
Structure Gallery
2281 structures found
CBLB
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Counted |
||
SETDB1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
CARM1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
PRMT3
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||
DCAF1
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||
53BP1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
53BP1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
pfPKG
Target Class: Kinase-Other Disease Areas: Parasitic disease Site: Toronto Status: MedChem |
||
EIF2A
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Counted |
||
COPB2
Target Class: WDR Disease Areas: Cancer Site: Toronto Status: MedChem |
||
COPB2
Target Class: WDR Disease Areas: Cancer Site: Toronto Status: Counted |
||
TRIP12
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling and cancer Site: Toronto Status: Counted |
||
DCAF1
Target Class: Ubiquitylation - E3 Ligases, WDR Disease Areas: Signalling Site: Toronto Status: MedChem |
||
CARM1
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||
PRMT9
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
SEC31A
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Counted |
||
DCAF1
Target Class: Ubiquitylation - E3 Ligases, WDR Disease Areas: Signalling and cancer Site: Toronto Status: MedChem |
||
GID4
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: MedChem |
||
GID4
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: MedChem |
||
UTP15
Target Class: WDR Disease Areas: Cancer Site: Toronto Status: Counted |
||
PRMT9
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||
PAFAH1B1
Target Class: WDR Disease Areas: Neurobiology Site: Toronto Status: Counted |
||
TMPRSS2
Target Class: Proteases Disease Areas: COVID Site: Toronto Status: Counted |
||
RBBP7
Target Class: WDR Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PPP1R10
Target Class: Miscellaneous Disease Areas: Cancer Site: Status: Counted |
||
WHSC1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
BRD1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||
EED
Target Class: WDR Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
WDR55
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Counted |
||
KIF21A
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Counted |
||
FEM1C
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Counted |
||
FEM1C
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Counted |
||
SCAF4
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Counted |
||
WHSC1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||
GID4
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
CVNSP3B
Target Class: Disease Areas: SARS-COV-2 Site: Frankfurt Status: |
||
CVNSP3B
Target Class: Disease Areas: SARS-COV-2 Site: Frankfurt Status: |
||
CVNSP3B
Target Class: Disease Areas: SARS-COV-2 Site: Frankfurt Status: |
||
FBXW11/SKP1 - Beta Catenin
Target Class: Ubiquitylation - E3 Ligases, WDR Disease Areas: Signalling and cancer Site: Toronto Status: Counted |
||
WDR41
Target Class: WDR Disease Areas: Cancer Site: Toronto Status: Counted |
||
PHF1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
PHF1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
PHF19
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
NLE1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Counted |
||
WDR91
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Counted |
||
PPP1R10
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Counted |
||
TEAD2
Target Class: Miscellaneous Disease Areas: Signalling and cancer Site: Toronto Status: Follow-up official |
||
UHRF1
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
53BP1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
TDRD3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||
CDYL2
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
ACVR1
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||
CDY1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
MPP8
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
CDYL2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||
ACVR1
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||
53BP1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
ACVR1
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||
ACVR1
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||
HAT1
Target Class: Chromatin Regulation, Transferases Disease Areas: Epigenetics Site: Toronto Status: Follow-up official |
||
DHTKD1
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Counted |
||
WHSC1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
ACVR1
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||
MAPK14A
Target Class: Protein Kinase/CMGC Disease Areas: Site: Frankfurt Status: Follow-up not counted |
||
BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||
RAB39B
Target Class: Vesicle Transport Disease Areas: Cancer Site: Oxford Status: Counted |
||
RAB38
Target Class: Vesicle Transport Disease Areas: Cancer Site: Oxford Status: Counted |
||
HUWE1
Target Class: Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
N6AMT1-TRMT112
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Counted |
||
PRMT9
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
COPA
Target Class: WDR Disease Areas: Neurobiology Site: Toronto Status: Counted |
||
HRMT1L6
Human protein arginine methyltransferase 6, full-length, in complex with covalent inhibitor YS17-117 Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
SUV39H2
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
WDR12
Target Class: Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Counted |
||
MSH6
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
MET12SCA
Target Class: Disease Areas: Site: Oxford Status: Official |
||
BDF2
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||
CLK3A
Target Class: Protein Kinase/CMGC Disease Areas: Site: Frankfurt Status: Not counted |
||
CLK1A
Target Class: Protein Kinase/CMGC Disease Areas: Site: Frankfurt Status: MedChem |
||
PRMT7
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
MECP2
Target Class: Chromatin Regulation Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
MECP2
Target Class: Chromatin Regulation Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
HMCES
Human 5-hydroxymethylcytosine binding ES cell specific, SRAP domain, in complex with 3' overhang DNA Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Toronto Status: Counted |
||
HMCES
Human 5-hydroxymethylcytosine binding ES cell specific, SRAP domain, cross-linked to DNA abasic site Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Toronto Status: Counted |
||
HMCES
Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Toronto Status: Not counted |
||
DYRK1AA
Target Class: Protein Kinase/CMGC Disease Areas: Signalling and cancer Site: Frankfurt Status: Not counted |
||
ACVR1A
Target Class: Protein Kinase/TKL Disease Areas: Site: Oxford Status: Follow-up not counted |
||
FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
PRDM9
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: MedChem |
||
SLC14A1A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Official |
||
MBTD1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
USP05
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling and cancer Site: Toronto Status: MedChem |
||
KCTD16A
Target Class: Ubiquitin Related Biology Disease Areas: Site: Oxford Status: Official |
||
ULK2A
Target Class: Protein Kinase Disease Areas: Autophagy and cancer Site: Frankfurt Status: Follow-up official |
||
ULK1A
Target Class: Protein Kinase Disease Areas: Autophagy and cancer Site: Frankfurt Status: Follow-up official |
||
ULK2A
Target Class: Protein Kinase Disease Areas: Autophagy and cancer Site: Frankfurt Status: Official |
||
ULK2A
Target Class: Protein Kinase Disease Areas: Autophagy and cancer Site: Frankfurt Status: Follow-up official |
||
PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||
PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
CLK1A
Target Class: Protein Kinase/CMGC Disease Areas: Signalling and cancer Site: Frankfurt Status: Follow-up not counted |
||
CLK1A
Target Class: Protein Kinase/CMGC Disease Areas: Signalling and cancer Site: Frankfurt Status: Follow-up not counted |
||
PP-BRD18
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
SPIN1A
Target Class: Protein Kinase/STE Disease Areas: Site: Oxford Status: Follow-up not counted |
||
SPIN1A
Target Class: SPINDLIN Disease Areas: Site: Oxford Status: Follow-up not counted |
||
SPIN1A
Target Class: SPINDLIN Disease Areas: Site: Oxford Status: Follow-up not counted |
||
WDR12
Target Class: WDR Disease Areas: Signalling and cancer Site: Toronto Status: Counted |
||
STK10A
Target Class: Protein Kinase/STE Disease Areas: Site: Oxford Status: Follow-up not counted |
||
STK10A
Target Class: Protein Kinase/STE Disease Areas: Site: Oxford Status: Follow-up not counted |
||
SLKA
Target Class: Protein Kinase/STE Disease Areas: Site: Oxford Status: Follow-up not counted |
||
MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: Follow-up official |
||
MLLT1A
Crystal structure of MLLT1 (ENL) YEATS domain in complexed with compound 94 (a SGC iMLLT derivative) Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: MedChem |
||
MLL3
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
SETD3
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
HUWE1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Counted |
||
MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: MedChem |
||
MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: MedChem |
||
MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: MedChem |
||
MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: MedChem |
||
MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: Follow-up not counted |
||
DDR1A
Target Class: Kinase-TK Disease Areas: Site: Oxford Status: Follow-up not counted |
||
PP-BRD12
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||
SETD3
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
RFXANK
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
RIOK2A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Official |
||
DYRK2
Target Class: Protein Kinase/CMGC Disease Areas: Cancer Site: Oxford Status: MedChem |
||
DYRK2
Target Class: Protein Kinase/CMGC Disease Areas: Cancer Site: Oxford Status: MedChem |
||
FYN
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Not counted |
||
HCN4A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Official |
||
USP05
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling and cancer Site: Toronto Status: MedChem |
||
KLHL20A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Follow-up official |
||
USP05
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling and cancer Site: Toronto Status: MedChem |
||
CARM1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||
DDR1A
Target Class: Kinase-TK Disease Areas: Site: Oxford Status: |
||
LOC149281
Target Class: Methyltransferases Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
STK10A
Target Class: Protein Kinase/STE Disease Areas: Site: Oxford Status: Follow-up not counted |
||
NUDT5A
Target Class: NUDIX Disease Areas: Site: Oxford Status: Follow-up official |
||
AURKC
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: Counted |
||
AURKC
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
STK6
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: MedChem |
||
GALTA
Target Class: Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
HAO1A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: |
||
GMDSA
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up not counted |
||
HAO1A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: |
||
GMDSA
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up not counted |
||
GMDSA
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up not counted |
||
HAO1A
Target Class: Disease Areas: Site: Oxford Status: |
||
FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
FAM83BA
Target Class: Cell Division Disease Areas: Site: Oxford Status: Follow-up not counted |
||
FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
ACVR1A
Target Class: Protein Kinase/TKL Disease Areas: Site: Oxford Status: |
||
ACVR1A
Target Class: Protein Kinase/TKL Disease Areas: Site: Oxford Status: |
||
MAPK3A
Target Class: Protein Kinase/CMGC Disease Areas: Signalling and cancer Site: Frankfurt Status: Follow-up not counted |
||
MBD1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
RFWD3
Target Class: WDR Disease Areas: Signalling and cancer Site: Toronto Status: Official |
||
MAPK1A
Target Class: Protein Kinase/CMGC Disease Areas: Signalling and cancer Site: Frankfurt Status: Follow-up not counted |
||
PP-BRD13
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Status: Counted |
||
CARM1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
MBD3
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
KCTD8A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Official |
||
SP100A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||
SP100A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||
XX01SUCLG1A
Target Class: Disease Areas: Site: Oxford Status: Official |
||
BRD2
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||
MBD2
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
DPAGT1A
Target Class: Membrane proteins Disease Areas: Neurobiology Site: Oxford Status: Follow-up official |
||
RIPK2
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||
MLLT10
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
MLLT10 - DOT1L
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
GID4
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling and metabolism Site: Toronto Status: Counted |
||
GID4
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling and metabolism Site: Toronto Status: Counted |
||
MBD3
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||
MBD2
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
MBD2
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
MBD2
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
ULK3
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
ULK3
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: Counted |
||
MTHFRA
Target Class: Disease Areas: Site: Oxford Status: Official |
||
PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
EHMT1
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||
L3MBTL1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||
WNK2A
Target Class: Protein Kinase/Other Disease Areas: Site: Oxford Status: |
||
RBBP4
Target Class: WDR Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||
RBBP4
Target Class: WDR Disease Areas: Cancer and epigenetics Site: Status: Follow-up official |
||
SETDB1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
B2MA
Target Class: Disease Areas: Site: Oxford Status: |
||
SETDB1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
SETDB1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
SETDB1
Target Class: Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||
SETDB1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||
SETDB1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||
RIPK2A
Target Class: Kinase-Other Disease Areas: Site: Oxford Status: |
||
STK10
Target Class: Protein Kinase/STE Disease Areas: Cancer Site: Oxford Status: MedChem |
||
FBXL19
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling and epigenetics Site: Toronto Status: Counted |
||
DENND1AA
Target Class: Disease Areas: Neurobiology Site: Oxford Status: Official |
||
WNK2A
Target Class: Protein Kinase/Other Disease Areas: Site: Oxford Status: |
||
JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||
JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||
JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||
JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||
TDRD2
Target Class: Methyl-lysine readers Disease Areas: Signalling and cancer Site: Toronto Status: Follow-up official |
||
JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||
JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||
SETDB1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Status: Follow-up not counted |
||
SETDB1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
TET1
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||
KANK1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Counted |
||
KANK1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Counted |
||
KANK2
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Follow-up not counted |
||
EED
Target Class: WDR Disease Areas: Cancer and epigenetics Site: Status: Follow-up official |
||
CXXC5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||
MBD1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
SUV420H1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
METTL13
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||
MYST1
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
SMYD2
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||
ABCB8A
Target Class: IMP/ABC Transporter Disease Areas: Metabolism Site: Oxford Status: Official |
||
HDAC6
Target Class: Transferases, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
HRMT1L6
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Status: Follow-up official |
||
SETD8
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||
DCLRE1AA
Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
DCLRE1AA
Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
DCLRE1AA
Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
DPAGT1A
Target Class: IMP/Enzyme Disease Areas: Neurobiology Site: Oxford Status: Follow-up official |
||
LIMK1A
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
LIMK2A
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
XX02KALRNA
Target Class: Disease Areas: Signalling Site: Oxford Status: Official |
||
WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Official |
||
WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Official |
||
WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
PARP14A
Target Class: Disease Areas: Metabolism Site: Oxford Status: Official |
||
AASSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
AASSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
AASSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
PP-BRD4
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||
BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||
BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||
BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||
BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||
KLHL3A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
DPYSL4A
Target Class: Disease Areas: Neurobiology Site: Oxford Status: Official |
||
XX09KEAP1A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Metabolism Site: Oxford Status: Official |
||
CXXC4
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
WHSC1
Target Class: Methyl-lysine readers Disease Areas: Cancer Site: Toronto Status: Official |
||
UBC
Target Class: Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
RPUSD1
Target Class: Oxidoreductases Disease Areas: Signalling Site: Toronto Status: Official |
||
USP09X
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
BAT8
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
EHMT1
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
RG9MTD1A
Target Class: Metabolic enzymes/Other Disease Areas: Metabolism Site: Oxford Status: Official |
||
SRPK1A
Target Class: Protein Kinase/CMGC Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
BRD2A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
SRPK2A
Target Class: Protein Kinase/CMGC Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
SRPK1A
Target Class: Protein Kinase/CMGC Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
YWHAZ
Target Class: Signalling proteins Disease Areas: Metabolism Site: Toronto Status: Follow-up official |
||
PGAM5A
Target Class: Phosphatases Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
RPUSD4
Target Class: Transferases Disease Areas: Chromatin and epigenetics, Signalling Site: Toronto Status: Pending-Official Structure |
||
LOC149281
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics, Signalling Site: Toronto Status: Pending-Official Structure |
||
TRIM33B
Target Class: Bromodomain, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Official |
||
PIP3EA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
PRKCBP1A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
BRD7A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PP-BRD3
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
XX02MOCS2A
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Oxford Status: Pending-Official Structure |
||
DCP2B
Target Class: NUDIX Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
DPYSL2A
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Oxford Status: Pending-Official Structure |
||
CARM1
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: MedChem |
||
DPYSL2A
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Oxford Status: Pending-Official Structure |
||
TAF1A
Target Class: Bromodomain Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up official |
||
CREBBP
Target Class: Bromodomain Disease Areas: Cancer, Metabolism, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
EED
Target Class: WDR Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: MedChem |
||
BAT8
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics, Neurobiology Site: Toronto Status: Follow-up not counted |
||
EHMT1
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
TDRD1A
Target Class: Methyl-lysine readers Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
SND1A
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PF08_0034
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Follow-up official |
||
BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
METTL3-METTL14
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
SETD8
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: MedChem |
||
FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
GEMIN5
Target Class: WDR Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
GEMIN5
Target Class: WDR Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
GEMIN5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
GEMIN5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PREB
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Toronto Status: Pending - Official structure |
||
GEMIN5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
DYRK2A
Target Class: Protein Kinase Disease Areas: Cancer, Metabolism, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
DYRK2A
Target Class: Protein Kinase Disease Areas: Cancer, Metabolism, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
JAK3A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
JAK3A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
NUDT4A
Target Class: NUDIX Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
SPIN2BA
Target Class: Chromatin Regulation Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
SETD8
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: MedChem |
||
NUDT7A
Target Class: NUDIX Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
CBX1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
CBX3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
NUDT17A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
DPAGT1A
Target Class: IMP/Enzyme Disease Areas: Metabolism Site: Oxford Status: Official |
||
PP-BRD19
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending - Official structure |
||
tesst
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending - Official structure |
||
PUS7
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending - Official structure |
||
RECQL5A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
RECQL5A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
RECQL5A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
RECQL5A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
HDAC6
Target Class: Transferases, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: MedChem |
||
HDAC6
Target Class: Ubiquitin Related Biology Disease Areas: Site: Toronto Status: MedChem |
||
SETDB1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
HDAC6
Target Class: Transferases, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: MedChem |
||
HDAC6
Target Class: Transferases, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: MedChem |
||
MAPK14A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
AASSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
AASSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
XX02LIMK1A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
AAK1A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Follow-up official |
||
PKD2A
Target Class: Membrane proteins Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
DOT1L
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
WNK1A
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
SART3
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
SART3
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PP-PKAR
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
CLK1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
CLK1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
TDRD2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
THYN1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
ZAKA
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Pending-Official Structure |
||
JMJD1CA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
GALTA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
BRD9A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1CA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
DPF3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
HRMT1L6
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
SIAH2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BRD1A
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PP-BRD19
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
DDR1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
DDR1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
EMG1
Target Class: Transferases Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
JMJD2AA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2DA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2DA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
CBX8
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
CBX7
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
CBX2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
CBX4
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BRD2A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
BRD9A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
HRMT1L6
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
PANK2
Target Class: Non-protein Kinase Disease Areas: Metabolism, Signalling Site: Toronto Status: Pending-Official Structure |
||
AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Follow-up not counted |
||
AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Follow-up not counted |
||
AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Follow-up not counted |
||
AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Follow-up not counted |
||
PP-PKG
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
PAHA
Target Class: Amino oxidases Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PP-PKG
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
ASPHA
Target Class: Amino oxidases Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
SMARCA2B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
SMARCA4A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
SMARCA2B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
XX05CRK7A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
PP-BRD18
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
POLQA
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
POLQA
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
GBE1A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
GBE1A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
KCTD17A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Metabolism Site: Oxford Status: Official |
||
PTPN11
Target Class: Phosphatases Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
PP-PKG
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
PP-BRD20
Target Class: Bromodomain Disease Areas: Site: Toronto Status: Pending-Official Structure |
||
ORC2
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
NEDD4
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Official |
||
ITCH
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Official |
||
BRPF1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
SLC2A3A
Target Class: Membrane proteins Disease Areas: Drug metabolism and toxicology Site: Oxford Status: Pending-Official Structure |
||
GRM7
Target Class: Miscellaneous Disease Areas: Signalling, Neurobiology Site: Toronto Status: Pending-Official Structure |
||
LdBPK_363130
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
SGF29
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
MMADHCMMA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending - Official structure |
||
JARID1BA
Target Class: Oxidoreductases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
DYRK1AA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Oxidoreductases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Oxidoreductases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
EP300A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BRD2A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
TIF1A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||
SPIN3A
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending - Official structure |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Site: Oxford Status: Pending - Official structure |
||
KCTD16A
Target Class: Ubiquitin Related Biology Disease Areas: Site: Oxford Status: Official |
||
CDK2A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
BRD1A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||
BRD1A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||
BRD9A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BRD9A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
TET3
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
KCTD13A
Target Class: Ubiquitin Related Biology Disease Areas: Site: Oxford Status: Official |
||
RC3H2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||
RC3H2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||
WHSC1L1
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
BRD1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PLRG1
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
RC3H1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||
PF13_0238
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
ZCWPW2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
ZCWPW2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
DYRK1AA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
DYRK1AA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
DYRK1AA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PG1424PGA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
PG1424PGA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
STK10A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
XX03GAKA
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
DYRK1AA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
PARP9B
Target Class: Poly ADP-ribose polymerase Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
DCLRE1AA
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
BRD9A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
POLQA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||
SHC1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
KCNK10C
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up official |
||
KCNK10C
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up official |
||
KCNK10C
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up official |
||
PP-PKG
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
KCTD10A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
C1ORF59
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
PP-MT10
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
GYG2A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
HRMT1L3
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
USP38
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
WHSC1L1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
SIAH1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer, Neurobiology Site: Toronto Status: Follow-up official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2DA
Target Class: Oxidoreductases Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2DA
Target Class: Oxidoreductases Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
JMJD2DA
Target Class: Oxidoreductases Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
ITCH
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||
ITCH
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||
ITCH
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Neurobiology Site: Toronto Status: Official |
||
VAV2
Target Class: G-Protein Regulators Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
AAK1A
Target Class: Non-protein Kinase Disease Areas: Site: Oxford Status: Pending - Official structure |
||
SPHK1B
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending - Official structure |
||
METTL18
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
C9orf114
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
53BP1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PVX_084705
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
MAGEA3A
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
YTHDF1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
YTHDF1
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
TPH2A
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Oxford Status: Pending-Official Structure |
||
BMP2KA
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending - Official structure |
||
BMP2KA
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
SEC14L3C
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
BTBD12B
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
SPIN4A
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending - Official structure |
||
YTHDC1
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
YTHDC1
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
CBSA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
RECQLA
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
ETV4A
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
UBH14
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
ASB11A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Oxford Status: Official |
||
SMARCA2B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending - Official structure |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending - Official structure |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
STK10A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
STK10A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
SLKA
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
HERC1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||
MAPK1A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
MAPK3A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
GSG2A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
MAPK8B
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
XX01MAPK1A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending - Official structure |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending - Official structure |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending - Official structure |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending - Official structure |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending - Official structure |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending - Official structure |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
DAPK1A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
KCNK2A
Target Class: Membrane proteins Disease Areas: Neurobiology Site: Oxford Status: Pending - Official structure |
||
JMJD2AA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
FAM83AA
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
UHRF1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
HTATIP
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
ANKRA2
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||
HRMT1L6
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
RFXANK
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||
PRMT3
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
MORC3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
SMN1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
HRMT1L6
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
METTL21B
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
PP-GCN5
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
PP-MAPK6
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
SHPRH
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
SEC14L4A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
ETV5A
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
GDAP2A
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
BAZ2AA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
XX05AKAP13A
Target Class: Signalling proteins Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
AKAP13A
Target Class: Signalling proteins Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
RPRD1B
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
RPRD1B
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||
BAZ2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
XX05CRK7A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
PB1A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
USP7
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
MLL4
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
ERCC6A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
ISPDA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
MLH1
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
PP-BRD3
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Pending - Official structure |
||
DCAF1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
CAMKMT
Target Class: Methyltransferases Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
SP100A
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
PRKCL2A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
SHKBP1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
TP53BP1A
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||
GSG2A
Target Class: Protein Kinase Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
PRKCBP1A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending - Official structure |
||
CBSA
Target Class: Nucleotide metabolism Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ETV4A
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
ALKBH5
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
CDYL2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
XX01CRK7A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending - Official structure |
||
KDM2B
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
CHD1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
YWHAG
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Follow-up not counted |
||
CHD1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
HERC1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||
PP-MAPK3
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
ALKBH5
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
ZCWPW2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Cancer, Metabolism, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Cancer, Metabolism, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Cancer, Metabolism, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
PF14_0724
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
MLL
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
KLHL2A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
KLHL3A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Official |
||
BLMA
Target Class: DExD-DExH RNA helicases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
STK4A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Cancer, Metabolism, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Cancer, Metabolism, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Metabolism, Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Cancer, Metabolism, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD9A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
XX08BLMA
Target Class: DExD-DExH RNA helicases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
MTRA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
NUDT1A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
NUDT1A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
RIPK2A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
JMJD1BA
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending - Official structure |
||
PVX_084705
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending - Official structure |
||
PF14_0346
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending - Official structure |
||
LdBPK
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Pending - Official structure |
||
PIAS3
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Pending - Official structure |
||
METTL21C
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD2A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD2A
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
XX01GAKA
Target Class: G-Protein Regulators, Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up official |
||
GAKA
Target Class: G-Protein Regulators, Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up official |
||
GAKA
Target Class: G-Protein Regulators, Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up official |
||
PCBD2A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ETS2A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
EZH2
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending - Official structure |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
GBE1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
BAZ2AA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
XX08ACVR1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
XX01MAPK14A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Follow-up official |
||
XX01MAPK14A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Follow-up official |
||
XX01MAPK14A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Follow-up official |
||
KCNK10C
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
METTL21D
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
ANKRA
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
MBD4
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
PRPF19
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
TBL1XR1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
METTL21A
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
PWWP2B
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
PP-GCN5
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
SET8
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
BRPF1B
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
L3MBTL3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
HERC2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Official |
||
GLS2A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
STK3A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
ETS2A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ETV1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
TSTA3A
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Signalling Site: Oxford Status: Follow-up official |
||
ZFYVE9C
Target Class: Signalling proteins Disease Areas: Signalling Site: Oxford Status: Pending-Official Structure |
||
TSTA3A
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism, Signalling Site: Oxford Status: Follow-up official |
||
DDR1A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Follow-up official |
||
DPYSL3A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending - Official structure |
||
DDR1A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Follow-up not counted |
||
FDPSA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
RRP9
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
RPRD1A
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
CDKL5A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
SNX14B
Target Class: G-Protein Regulators Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
PP-CDPK3
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending - Official structure |
||
ACVR1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
RNF31
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Pending - Official structure |
||
SETD7
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
FEVA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
SETD7
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
TYK2A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
DDR1A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
MYO5AA
Target Class: Miscellaneous Disease Areas: Signalling Site: Oxford Status: Pending-Official Structure |
||
MYO5BA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
GLOD4A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
CARM1
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
XX03CAB39LA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
SETD8
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PRDM9
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
ITSN1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
ITSN2
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Toronto Status: Pending-Official Structure |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
ZGPAT
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
SORBS2
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
ZRF1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PY06420
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
ABCB10A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up not counted |
||
CDKL3A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending - Official structure |
||
NUP43
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Official |
||
DCLRE1BA
Target Class: Nuclear Receptors Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
FEVA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
SNX3A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ZMPSTE24A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up official |
||
JMJD1CA
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
HRMT1L3
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
PP-ClpR
Target Class: Proteases Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
HRMT1L6
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
FBXL11A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
SNX27A
Target Class: PDZ linkers Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
KANK2
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
CDKL2A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Follow-up not counted |
||
CDYL2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
EHMT1
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
NEK1A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
MAPK7A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
TSTA3A
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Signalling Site: Oxford Status: Pending - Official structure |
||
TSTA3A
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism, Signalling Site: Oxford Status: Pending Not counted |
||
DCLRE1AA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending - Official structure |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
PP-ClpR
Target Class: Proteases Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
DNMBP
Target Class: G-Protein Regulators Disease Areas: Neurobiology Site: Toronto Status: Pending-Official Structure |
||
C14ORF124A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
JMJD2AA
Target Class: Oxidoreductases Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
CHD1A
Target Class: DExD-DExH RNA helicases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
MLL5
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
USP28
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Official |
||
PP-MetAP
Target Class: Proteases Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
ETV1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
RPRD1B
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending - Official structure |
||
PSIP1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending - Official structure |
||
YANK1A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
DYRK2A
Target Class: Protein Kinase Disease Areas: Cancer, Metabolism, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
DYRK1AA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
SNX24A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ABCB10A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up not counted |
||
PIAS2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
SETD2
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
RG9MTD2
Target Class: Transferases Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
BRDTA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
RPRD1B
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending - Official structure |
||
RPRD2
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending - Official structure |
||
RPRD1B
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending - Official structure |
||
L3MBTL3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
ZMPSTE24A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
NCOR2
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
HGSA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
CDC42BPAA
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ETV1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
BIN2A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
CD36B2
Target Class: Miscellaneous Disease Areas: Metabolism Site: Toronto Status: Pending-Official Structure |
||
ACVR2A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
ACACAA
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
KBTBD5A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
DOT1L
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
DOT1L
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
DOT1L
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
DOT1L
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
DOT1L
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
DOT1L
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
NEK1A
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
XX06CUL3A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
MOCS2
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
XX01CUL3A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up not counted |
||
PP-LeuAP
Target Class: Proteases Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
STK10A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up official |
||
PP-ASL
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
SCML2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
FESA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
PLXNB2
Target Class: G-Protein Regulators Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
PLXNA4A
Target Class: G-Protein Regulators Disease Areas: Cancer, Signalling Site: Toronto Status: Pending-Official Structure |
||
SETD7
Target Class: Transferases Disease Areas: Metabolism, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
SNX33A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
FESA
Target Class: Non-protein Kinase, Nucleotide metabolism Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
ACVR1A
Target Class: Nucleotide metabolism, Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up official |
||
PHF8A
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics, Neurobiology Site: Oxford Status: Follow-up official |
||
CDKL1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Pending - Official structure |
||
FKBP14A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
FLJ21802A
Target Class: Oxidoreductases Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Pending-Official Structure |
||
XX07AURKBA
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
LACTB2A
Target Class: Miscellaneous Disease Areas: Cancer, Metabolism Site: Oxford Status: Pending-Official Structure |
||
USP02
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up not counted |
||
USP02
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up official |
||
ANKRA
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
ANKRA
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||
RFXANK
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
ANKRA
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
TTC5MM
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up not counted |
||
YWHAG
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
RFXANK
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
FLJ13798A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
L3MBTL1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
DOT1L
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
CDKL2A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ABCB10A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up not counted |
||
XX13GUCY1A3A
Target Class: Nucleotide metabolism, Signalling proteins Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
TP73LA
Target Class: Miscellaneous Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Pending-Official Structure |
||
FALZA
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||
TAF1A
Target Class: Bromodomain Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
TAF1A
Target Class: Bromodomain Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
SMARCA4A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||
L3MBTL3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PP-GMPS
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
LMNB2
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
DMTF1
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
XX01TP73A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending - Official structure |
||
CUL4BA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
FABP9A
Target Class: Lipid signalling Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up not counted |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
PKM2
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
AMPHA
Target Class: Miscellaneous Disease Areas: Signalling Site: Oxford Status: Follow-up not counted |
||
AMPHA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up not counted |
||
RTF1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
CD2APA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ENOSF1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
USP37
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
KIAA1576A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ITCH
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Official |
||
ENDOGL1A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Stockholm Status: Pending-Official Structure |
||
ROR2A
Target Class: Protein Kinase Disease Areas: Signalling Site: Stockholm Status: Pending-Official Structure |
||
STK10A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Pending-Official Structure |
||
PP-AK
Target Class: Non-protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
TXNL2A
Target Class: Oxidoreductases Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
HGSA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
PP-1CYS-PRX
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
ZFYVE16A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
GLOD5A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ELAC1A
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
DOT1L
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Cancer, Metabolism, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
MMACHCA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ACVR2A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
MAGI3A
Target Class: PDZ linkers Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
AMPHA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
HECW2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Official |
||
ANKRA
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending - Official structure |
||
EIF4E
Target Class: G-Protein Regulators Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
CYP7A1
Target Class: Miscellaneous Disease Areas: Metabolism Site: Toronto Status: Follow-up official |
||
PARP14A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
PARP14A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
PANK1
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Follow-up official |
||
HRMT1L3
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
WDR5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PANK3
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Follow-up official |
||
SETD3
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
PARP14A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
GRM3
Target Class: Membrane proteins Disease Areas: Neurobiology Site: Toronto Status: Pending-Official Structure |
||
ACACAA
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
LIMK1A
Target Class: Phosphoinosotide dependent signalling Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
BRD3A
Target Class: Bromodomain Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
BRD3A
Target Class: Bromodomain Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
TDRD5
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending - Official structure |
||
ABCB10A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
SETD1A
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
SUV420H1
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
DDI1
Target Class: Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
PP-MetAP
Target Class: Proteases Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
TPK1
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Pending-Official Structure |
||
RYR1
Target Class: Proteases Disease Areas: Metabolism Site: Toronto Status: Pending-Official Structure |
||
C1QBP
Target Class: Miscellaneous Disease Areas: Cancer, Metabolism Site: Toronto Status: Pending-Official Structure |
||
SUV420H2
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
PP-MAPK2
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
BAIAP2A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
MCEEA
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
MLYCDA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
HECTD1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||
PRDM11
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
MLH1
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
ASPHA
Target Class: Oxidoreductases Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
BRD1A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
MTMR6A
Target Class: Phosphoinosotide dependent signalling Disease Areas: Signalling Site: Stockholm Status: Pending-Official Structure |
||
PIP4K2AA
Target Class: Protein Kinase Disease Areas: Neurobiology Site: Stockholm Status: Pending-Official Structure |
||
TDRD7
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
CLK3A
Target Class: Protein Kinase Disease Areas: Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||
MCTS1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
MPP8
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
TBC1D7
Target Class: G-Protein Regulators Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
IQSEC1A
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
SMYD3
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
GMIP
Target Class: G-Protein Regulators Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
HBP1A
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Pending-Official Structure |
||
TXNL2A
Target Class: Oxidoreductases Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
SFTPCA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Stockholm Status: Pending-Official Structure |
||
ERAP1A
Target Class: Miscellaneous Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
CXXC1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
CXXC1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
CXXC1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
CXXC1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
CXXC1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
CXXC1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
PP-G6PI
Target Class: Miscellaneous Disease Areas: Metabolism, Parasitic disease Site: Toronto Status: Pending Not counted |
||
DNMT3B
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
ANLNA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
PHKG2A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
CRYBB3A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
HDGF2
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
EPB41
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
PREX1
Target Class: G-Protein Regulators Disease Areas: Cancer, Metabolism Site: Toronto Status: Pending-Official Structure |
||
PIWIL2
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
PHF20
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
HDGF2
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PARP14A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Pending-Official Structure |
||
PARP14A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Pending-Official Structure |
||
G3BP1A
Target Class: Nucleotide metabolism Disease Areas: Cancer, Signalling Site: Stockholm Status: Pending-Official Structure |
||
NUDT14A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Metabolism Site: Stockholm Status: Pending-Official Structure |
||
NUDT1A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Drug metabolism and toxicology Site: Stockholm Status: Pending-Official Structure |
||
PP-CDPK1
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
GYG1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
ACVR1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
ACVR2A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
PLXNA2
Target Class: G-Protein Regulators, GTPases Disease Areas: Neurobiology Site: Toronto Status: Pending-Official Structure |
||
WDR9A
Target Class: Bromodomain Disease Areas: Epigenetics Site: Oxford Status: Pending-Official Structure |
||
BAZ2B
Target Class: Bromodomain Disease Areas: Epigenetics Site: Oxford Status: Pending-Official Structure |
||
TRIM54
Target Class: Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
PHF20
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
TATDN3A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
NFATC2IP
Target Class: Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
HSP90B1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
TGM1A
Target Class: Miscellaneous Disease Areas: Cancer, Metabolism Site: Oxford Status: Pending-Official Structure |
||
LTB4DHA
Target Class: Oxidoreductases Disease Areas: Cancer, Signalling, Drug metabolism and toxicology Site: Oxford Status: Follow-up official |
||
MAST1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
PP-G6PI
Plasmodium falciparum glucose-6-phosphate isomerase (PF14_0341), in complex with glucose-6-phosphate Target Class: Miscellaneous Disease Areas: Metabolism, Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
USP15
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
ARHGAP27A
Target Class: G-Protein Regulators Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
TDRD3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
TDRD3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
MUM1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
PP-CDPK2
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
JMJD3A
Target Class: Oxidoreductases Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Pending-Official Structure |
||
SIRT6
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
TTC5A
Target Class: Signalling proteins Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
RAMP2A
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
DTX3L
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||
THB
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
BRPF3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
CBLBA
Target Class: Signalling proteins, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
GAPDHSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||
OTUD5
Target Class: Deubiquitinating Enzymes - Non-USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
NADK
Target Class: Non-protein Kinase Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
L3MBTL1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PP-RABGDI
Target Class: G-Protein Regulators Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
EPHB3
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Pending-Official Structure |
||
GIMAP2
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
LCN15A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
INPP5EA
Target Class: Phosphoinosotide dependent signalling Disease Areas: Signalling Site: Stockholm Status: Pending-Official Structure |
||
ENO3A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
PKMYT1A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Cancer, Metabolism, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Pending-Official Structure |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Metabolism, Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Metabolism, Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Metabolism, Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
FDX1A
Target Class: Miscellaneous Disease Areas: Metabolism, Signalling, Drug metabolism and toxicology Site: Oxford Status: Pending-Official Structure |
||
NUDT16A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Metabolism Site: Stockholm Status: Follow-up official |
||
TNKS2A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
TNKS2A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
TNKS2A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
NISCHA
Target Class: Phosphoinosotide dependent signalling Disease Areas: Signalling Site: Stockholm Status: Pending-Official Structure |
||
PIK3R2A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Stockholm Status: Pending-Official Structure |
||
PP-MAPK1
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
UHRF1
Target Class: Ubiquitin Related Biology Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Toronto Status: Follow-up official |
||
WDR61
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
ERI3A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Stockholm Status: Pending-Official Structure |
||
UPASE2A
Target Class: Nucleotide metabolism Disease Areas: Metabolism Site: Stockholm Status: Pending-Official Structure |
||
ACVR1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
BRD2A
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: Pending Not counted |
||
TKTA
Target Class: Transferases Disease Areas: Cancer, Metabolism, Signalling, Neurobiology Site: Oxford Status: Pending-Official Structure |
||
CBLCA
Target Class: Signalling proteins, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
CDC25CA
Target Class: Phosphatases Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
VRK1A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
P100
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
P100
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
MPSTA
Target Class: AA metabolic enzymes Disease Areas: Metabolism Site: Stockholm Status: Pending-Official Structure |
||
UBH14
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Toronto Status: Pending-Official Structure |
||
OTUD7A
Target Class: Deubiquitinating Enzymes - Non-USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
RHEBL1A
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
PHF13
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
KLHL2A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
PHF13
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
HLTF
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
JMJD2CA
Target Class: Oxidoreductases Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
DHRS4A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
PP-CDPK3
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
ARFGAP1
Target Class: G-Protein Regulators Disease Areas: Cancer, Neurobiology Site: Toronto Status: Pending-Official Structure |
||
MPP7
Target Class: Non-protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Pending-Official Structure |
||
BBOX1A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up not counted |
||
PGAM5A
Target Class: Phosphatases Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
CECR2A
Target Class: Bromodomain Disease Areas: Epigenetics Site: Oxford Status: Pending-Official Structure |
||
ABL2A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
EPHA7
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Pending-Official Structure |
||
TP73A
Target Class: Miscellaneous Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Pending-Official Structure |
||
MUTA
Target Class: Miscellaneous Disease Areas: Metabolism, Cancer, Neurobiology Site: Oxford Status: Follow-up official |
||
YSK1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Pending-Official Structure |
||
TATDN1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
MUTA
Target Class: Miscellaneous Disease Areas: Metabolism, Cancer, Neurobiology Site: Oxford Status: Follow-up official |
||
PMP2A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
INPPL1BA
Target Class: Phosphoinosotide dependent signalling Disease Areas: Metabolism, Signalling Site: Stockholm Status: Official |
||
CLK2A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
BAT8
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
PP-MAPK2
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PP-AHA1
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
KNS2
Target Class: Miscellaneous Disease Areas: Cancer, Neurobiology Site: Toronto Status: Official |
||
MPP1
Target Class: Non-protein Kinase Disease Areas: Signalling Site: Toronto Status: Official |
||
CYP11A1
Target Class: Miscellaneous Disease Areas: Metabolism, Drug metabolism and toxicology Site: Toronto Status: Pending-Official Structure |
||
CYP11A1
Target Class: Miscellaneous Disease Areas: Metabolism, Drug metabolism and toxicology Site: Toronto Status: Follow-up official |
||
CYP11A1
Target Class: Miscellaneous Disease Areas: Metabolism, Drug metabolism and toxicology Site: Toronto Status: Follow-up official |
||
MLH1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
CPSF5A
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Pending-Official Structure |
||
INPP5BA
Target Class: Phosphoinosotide dependent signalling Disease Areas: Signalling Site: Stockholm Status: Official |
||
PP-MAPK2
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
HSPA9A
Target Class: ATPases Disease Areas: Cancer Site: Stockholm Status: Pending-Official Structure |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
EBF3A
Target Class: Miscellaneous Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
USP08
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
DPP7
Target Class: Proteases Disease Areas: Site: Toronto Status: Follow-up official |
||
ACVRL1A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
MINAB
Target Class: Oxidoreductases Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Pending-Official Structure |
||
ERAP1A
Target Class: Proteases Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Pending-Official Structure |
||
PGAM5A
Target Class: Phosphatases Disease Areas: Signalling Site: Oxford Status: Pending-Official Structure |
||
JMJD2CA
Target Class: Oxidoreductases Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||
EBF3A
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Stockholm Status: Pending-Official Structure |
||
GHRHRA
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
PCTK1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Pending-Official Structure |
||
USP21
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
ACVR1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Pending-Official Structure |
||
INPP5BA
Target Class: Phosphoinosotide dependent signalling Disease Areas: Signalling Site: Stockholm Status: Pending-Official Structure |
||
AHCYL1A
Target Class: AA metabolic enzymes Disease Areas: Cancer, Metabolism Site: Stockholm Status: Pending-Official Structure |
||
SUV39H1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
H2AFY2A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
BBOX1A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||
PP-CDPK6
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
EBF1A
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Stockholm Status: Pending-Official Structure |
||
ASH1LA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Pending-Official Structure |
||
FGD5
Target Class: G-Protein Regulators Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
GRM7
Target Class: Membrane proteins Disease Areas: Neurobiology Site: Toronto Status: Official |
||
LMNB1
Target Class: Miscellaneous Disease Areas: Site: Toronto Status: Pending-Official Structure |
||
BRPF1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
TNKS2A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
TNKS2A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
XX01ASB9A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Follow-up official |
||
CA7A
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Oxford Status: Pending |
||
PKM2
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
SGF29
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
SGF29
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
PP-ChK
Target Class: Non-protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
SGF29
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
SGF29
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
SGF29
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
SMYD3
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending |
||
XX01ASB9A
Target Class: Signalling proteins Disease Areas: Site: Oxford Status: Pending |
||
PP-PYRK1
Target Class: Non-protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
XX01BMPR1BA
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending |
||
SGF29
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
NUDT10A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Signalling Site: Stockholm Status: Pending |
||
USP7
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Pending |
||
EPHA2
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Pending |
||
MAT2BB
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Drug metabolism and toxicology Site: Oxford Status: Pending-Official Structure |
||
MAT2BB
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Drug metabolism and toxicology Site: Oxford Status: Pending-Official Structure |
||
PHIPA
Target Class: Bromodomain Disease Areas: Epigenetics Site: Oxford Status: Pending |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
SEPX1A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
NVLA
Target Class: ATPases Disease Areas: Neurobiology Site: Stockholm Status: Pending |
||
EBF1A
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Stockholm Status: Pending |
||
TNIKA
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending |
||
SRPK2A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending |
||
MGC45594A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
DDX18A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Stockholm Status: Pending |
||
BRD1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending |
||
KIAA1240A
Target Class: Bromodomain Disease Areas: Epigenetics Site: Oxford Status: Pending |
||
GIMAP1
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Pending |
||
GIMAP4
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Pending |
||
MPP8
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending |
||
CRYBA4A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending |
||
SGF29
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending |
||
PIK3C3A
Target Class: Phosphoinosotide dependent signalling Disease Areas: Cancer, Signalling Site: Stockholm Status: Follow-up official |
||
ZC3HAV1A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Pending |
||
VIPR2A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Pending |
||
USP15
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Cancer, Signalling Site: Toronto Status: Pending |
||
GRM5
Target Class: Membrane proteins Disease Areas: Neurobiology Site: Toronto Status: Pending |
||
LHPPA
Target Class: Miscellaneous Disease Areas: Metabolism, Signalling, Neurobiology Site: Oxford Status: Pending |
||
LOC340156A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Pending |
||
DHX9A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Stockholm Status: Pending |
||
DNMT3A
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending |
||
PP-LAMMER
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
RRAGC
Target Class: GTPases Disease Areas: Cancer, Signalling Site: Toronto Status: Pending |
||
STK17BA
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Pending |
||
STK17BA
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||
GAKA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Pending |
||
MACROD1A
Target Class: Miscellaneous Disease Areas: Metabolism, Chromatin and epigenetics, Signalling Site: Oxford Status: Pending |
||
CENTA1
Target Class: G-Protein Regulators Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
PP-CDPK1
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
MGC45594A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending |
||
PP-HSP70
Target Class: ATPases Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
AKT3A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Pending |
||
HDHD1AA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending |
||
GMFGA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending |
||
HECW1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Official |
||
PP-HSP70
Target Class: ATPases Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
BRPF1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
DYN3
Target Class: GTPases Disease Areas: Cancer Site: Toronto Status: Pending |
||
ECT2
Target Class: G-Protein Regulators Disease Areas: Cancer Site: Toronto Status: Pending |
||
PP-CDPK1
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
SDHLA
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending |
||
CUL5A
Target Class: Signalling proteins Disease Areas: Site: Oxford Status: Pending |
||
PP-HSP70
Target Class: ATPases Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
NUDT16L1A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Cancer Site: Stockholm Status: Pending |
||
DYRK2A
Target Class: Protein Kinase Disease Areas: Cancer, Metabolism, Signalling, Neurobiology Site: Oxford Status: Pending |
||
RNF168
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer, Neurobiology Site: Toronto Status: Pending |
||
PLXNC1
Target Class: G-Protein Regulators Disease Areas: Cancer Site: Toronto Status: Pending |
||
DLC1
Target Class: G-Protein Regulators Disease Areas: Cancer Site: Toronto Status: Pending |
||
FXR1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics, Neurobiology Site: Toronto Status: Follow-up not counted |
||
EPHA8
Target Class: Protein Kinase Disease Areas: Signalling Site: Toronto Status: Pending |
||
CBX3
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending |
||
FXR1
Target Class: Methyl-lysine readers Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
PP-CDPK14
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
TXNL2A
Target Class: Oxidoreductases Disease Areas: Cancer, Signalling Site: Oxford Status: Pending |
||
GUCY1B3A
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending |
||
GRM1
Target Class: Miscellaneous Disease Areas: Site: Toronto Status: Pending |
||
TNKS2A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Pending |
||
TNKS2A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up official |
||
HMGCS2A
Target Class: Transferases Disease Areas: Site: Oxford Status: Official |
||
RECQLA
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||
UGDHA
Target Class: Oxidoreductases Disease Areas: Metabolism, Signalling, Neurobiology, Drug metabolism and toxicology Site: Oxford Status: Follow-up official |
||
RALGDS
Target Class: G-Protein Regulators Disease Areas: Cancer Site: Toronto Status: Pending |
||
MMAAA
Target Class: Miscellaneous Disease Areas: Metabolism, Neurobiology Site: Oxford Status: Pending |
||
PARP15A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Official |
||
PP-PYRK1
Target Class: Non-protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
PP-CDPK1
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
MAST3A
Target Class: PDZ linkers Disease Areas: Signalling Site: Oxford Status: Pending |
||
EPHA1
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Pending |
||
PHF8A
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics, Neurobiology Site: Oxford Status: Pending |
||
TJP3
Target Class: Non-protein Kinase Disease Areas: Site: Toronto Status: Pending |
||
PTGDSA
Target Class: Miscellaneous Disease Areas: Signalling Site: Stockholm Status: Pending |
||
PIK3C2GA
Target Class: Phosphoinosotide dependent signalling Disease Areas: Cancer Site: Stockholm Status: Pending |
||
PARP2A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Pending |
||
PARP2A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up official |
||
HERC2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Toronto Status: Official |
||
BAT8
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
GLRX5A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Official |
||
SIRT6
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending |
||
PTDSRB
Target Class: Oxidoreductases Disease Areas: Signalling Site: Oxford Status: Pending |
||
CLK3A
Target Class: Protein Kinase Disease Areas: Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
CLK3A
Target Class: Protein Kinase Disease Areas: Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
ACOT4A
Target Class: Lipid signalling Disease Areas: Metabolism Site: Stockholm Status: Official |
||
PB1A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
DYRK2A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending |
||
PP-CDPK3
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
HDHD3A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending |
||
CTSL1
Target Class: Proteases Disease Areas: Metabolism Site: Toronto Status: Follow-up official |
||
MALT1
Target Class: Proteases Disease Areas: Cancer Site: Toronto Status: Pending |
||
ITSN2
Target Class: G-Protein Regulators Disease Areas: Signalling, Neurobiology Site: Toronto Status: Pending |
||
USP04
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Pending |
||
PP-SIR2
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
NMT1
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
EED
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
NMT1
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
IQGAP3
Target Class: G-Protein Regulators Disease Areas: Cancer, Signalling Site: Toronto Status: Pending |
||
UBI-D4
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending |
||
HSPA5A
Target Class: ATPases Disease Areas: Cancer Site: Stockholm Status: Official |
||
RICS
Target Class: G-Protein Regulators Disease Areas: Neurobiology Site: Toronto Status: Pending |
||
DDX53A
Target Class: ATPases Disease Areas: Cancer Site: Stockholm Status: Official |
||
UBC80
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Cancer Site: Toronto Status: Pending |
||
CTSL1
Target Class: Proteases Disease Areas: Metabolism Site: Toronto Status: Pending-Official Structure |
||
PB1A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
PB1A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
NMT1
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
NMT1
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
UGDHA
Target Class: Oxidoreductases Disease Areas: Metabolism, Signalling, Neurobiology, Drug metabolism and toxicology Site: Oxford Status: Follow-up official |
||
HPDA
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending |
||
PP-CDPK6
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
HTD2A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending |
||
SNX7BA
Target Class: Phosphoinosotide dependent signalling Disease Areas: Signalling Site: Stockholm Status: Official |
||
GSG2A
Target Class: Protein Kinase Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
CENTG3
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Pending |
||
GOT1A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending |
||
USP05
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Pending |
||
PRDM10
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending |
||
PIK3C3A
Target Class: Non-protein Kinase Disease Areas: Cancer, Signalling Site: Stockholm Status: Official |
||
KLHL7B
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Pending |
||
GPT2A
Target Class: AA metabolic enzymes Disease Areas: Metabolism Site: Stockholm Status: Official |
||
CTPS2A
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
MBD4
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending |
||
PP-CDPK4
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
IQGAP2
Target Class: G-Protein Regulators Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
DYRK1AA
Target Class: Protein Kinase Disease Areas: Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
RPS6KA1A
Target Class: Protein Kinase Disease Areas: Signalling, Neurobiology Site: Oxford Status: Pending |
||
UMPSA
Target Class: Nucleotide metabolism Disease Areas: Metabolism Site: Stockholm Status: Official |
||
RNF128
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Metabolism, Signalling Site: Toronto Status: Pending |
||
ADAA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending |
||
CBX8
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
CYP51A1
Target Class: Miscellaneous Disease Areas: Drug metabolism and toxicology Site: Toronto Status: Pending |
||
LOC116143
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Counted |
||
UBQLN1
Target Class: Ubiquitin Related Biology Disease Areas: Neurobiology Site: Toronto Status: Pending |
||
MGC5987A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending |
||
NMRAL1A
Target Class: Oxidoreductases Disease Areas: Metabolism, Signalling Site: Oxford Status: Follow-up not counted |
||
HSPA2A
Target Class: ATPases Disease Areas: Cancer Site: Stockholm Status: Official |
||
LASP1A
Target Class: Cell-type specific expression Disease Areas: Cancer, Signalling Site: Stockholm Status: Official |
||
CBX5
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Counted |
||
EP300A
Target Class: Bromodomain Disease Areas: Cancer, Metabolism, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Pending |
||
KLHL11A
Target Class: BTB-Kelch, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Pending |
||
USP21
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
NMRAL1A
Target Class: Oxidoreductases Disease Areas: Metabolism, Signalling Site: Oxford Status: Pending |
||
PTSA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending |
||
MOCS3
Target Class: Ubiquitin Related Biology, Ubiquitylation - E1 Enzymes Disease Areas: Metabolism Site: Toronto Status: Counted |
||
PP-CDPK1
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||
HHL
Target Class: G-Protein Regulators Disease Areas: Cancer Site: Toronto Status: Counted |
||
PP-CDPK4
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||
FLT1A
Target Class: Protein Kinase Disease Areas: Cancer Site: Stockholm Status: Official |
||
DMAP
Target Class: Transferases Disease Areas: Site: Toronto Status: Official |
||
EHMT1
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
ABL2A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
HDHD2A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending |
||
BRD9A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Official |
||
PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Pending |
||
TAF1LA
Target Class: Bromodomain Disease Areas: Epigenetics Site: Oxford Status: Pending |
||
PLXNB1
Target Class: G-Protein Regulators Disease Areas: Cancer Site: Toronto Status: Counted |
||
HK3
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Counted |
||
PARP10A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Official |
||
PP-CDPK10
Target Class: Malaria Disease Areas: Site: Toronto Status: Pending |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Site: Toronto Status: Official |
||
EPHA1
Target Class: Protein Kinase Disease Areas: Site: Toronto Status: Official |
||
XX01ACVR1A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Official |
||
ACBD4A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Official |
||
NUDT6A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Cancer Site: Stockholm Status: Official |
||
GAPDHSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
TTKA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
TBSAHA
Target Class: AA metabolic enzymes Disease Areas: Parasitic disease Site: Stockholm Status: Official |
||
RNF2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Counted |
||
TXNRD3A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
UBA05
Target Class: Ubiquitin Related Biology, Ubiquitylation - E1 Enzymes Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
EPHA7
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Counted |
||
CBX2
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Counted |
||
FXR2
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Counted |
||
PP-HSP90
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PLXND1
Target Class: G-Protein Regulators Disease Areas: Site: Toronto Status: Pending - Official structure |
||
PKM2
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
PP-NMT
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
RRM1A
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
ABL2A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending |
||
PPT1
Target Class: Miscellaneous Disease Areas: Site: Toronto Status: Official |
||
PP-CDPK4
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
MGC45594A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Official |
||
XX02CAMK2DA
Target Class: Protein Kinase Disease Areas: Metabolism, Chromatin and epigenetics, Neurobiology Site: Oxford Status: Pending |
||
PKM2
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
PKM2
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
KIAA0828A
Target Class: AA metabolic enzymes Disease Areas: Metabolism, Cancer Site: Stockholm Status: Official |
||
BPNT1A
Target Class: Nucleotide metabolism Disease Areas: Neurobiology Site: Stockholm Status: Official |
||
HDAC6
Target Class: Ubiquitin Related Biology Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Counted |
||
CBX6
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||
UBA05
Target Class: Ubiquitin Related Biology, Ubiquitylation - E1 Enzymes Disease Areas: Signalling Site: Toronto Status: Counted |
||
PP-UDPGP
Target Class: Miscellaneous Disease Areas: Metabolism, Parasitic disease Site: Toronto Status: Counted |
||
LOC148158A
Target Class: Disease Areas: Site: Oxford Status: Follow-up not counted |
||
PARP14A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Official |
||
MAPK11A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Pending |
||
MST4A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending |
||
ACAD11A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Official |
||
GIPC2A
Target Class: Linkers Disease Areas: Signalling Site: Oxford Status: Pending |
||
PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Official |
||
TTKA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Pending |
||
NXR1A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Site: Stockholm Status: Official |
||
PP-PYRK1
Target Class: Non-protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
ITSN2
Target Class: G-Protein Regulators Disease Areas: Neurobiology, Signalling Site: Toronto Status: Counted |
||
PARP15A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Official |
||
RBBP4
Target Class: Miscellaneous Disease Areas: Site: Toronto Status: Official |
||
HSPA1LA
Target Class: ATPases Disease Areas: Site: Stockholm Status: Official |
||
KIF13B
Target Class: Miscellaneous Disease Areas: Cancer, Neurobiology Site: Toronto Status: Counted |
||
PKM2
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
MAGEA4A
Target Class: Miscellaneous Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
GLRX5A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
BMPR2A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Official |
||
SETD2
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
HERC2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Toronto Status: Official |
||
HUWE1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Toronto Status: Official |
||
LMSAHA
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Stockholm Status: Official |
||
BAZ2BA
Target Class: Bromodomain Disease Areas: Epigenetics Site: Oxford Status: Official |
||
DDX19A
Target Class: ATPases Disease Areas: Cancer Site: Stockholm Status: Official |
||
PB1A
Target Class: Bromodomain Disease Areas: Epigenetics Site: Oxford Status: Official |
||
FLJ20257
Target Class: Transferases Disease Areas: Site: Toronto Status: Official |
||
ZADH1A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
NUDT6A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Cancer Site: Stockholm Status: Official |
||
PP-CPUF2
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||
FLJ22313
Human homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 2 Target Class: Ubiquitin Related Biology Disease Areas: Site: Toronto Status: Official |
||
SNX17A
Target Class: Phosphoinosotide dependent signalling Disease Areas: Site: Stockholm Status: Official |
||
TBCTPSA
Target Class: Nucleotide metabolism Disease Areas: Parasitic disease Site: Stockholm Status: Official |
||
DNMT3B
Target Class: Transferases Disease Areas: Epigenetics Site: Toronto Status: Official |
||
ACOT11A
Target Class: Lipid signalling Disease Areas: Site: Stockholm Status: Official |
||
MAST4A
Target Class: Linkers Disease Areas: Site: Oxford Status: Official |
||
GSG2A
Target Class: Protein Kinase Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
MAP2K6A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending |
||
ACBD5A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Official |
||
CENTA1
Target Class: G-Protein Regulators Disease Areas: Signalling Site: Toronto Status: Official |
||
PP-ChK
Target Class: Non-protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||
UHRF1
Target Class: Ubiquitin Related Biology Disease Areas: Site: Toronto Status: Official |
||
EPHA2
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Counted |
||
PP-BRD1
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Counted |
||
ZBTB33A
Target Class: BTB-Kelch Disease Areas: Metabolism, Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Official |
||
GRLF1
Target Class: G-Protein Regulators Disease Areas: Cancer, Signalling Site: Toronto Status: Counted |
||
CENTA1
Target Class: G-Protein Regulators Disease Areas: Signalling Site: Toronto Status: Counted |
||
ZADH1A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||
TDRD2
Target Class: Methyl-lysine readers Disease Areas: Epigenetics Site: Toronto Status: Official |
||
CBX5
Target Class: Methyl-lysine readers Disease Areas: Epigenetics Site: Toronto Status: Official |
||
CHKB
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Follow-up official |
||
MBTD1
Target Class: Methyl-lysine readers Disease Areas: Epigenetics Site: Toronto Status: Official |
||
CAMK4A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
DCTDA
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
NANPA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Official |
||
DDX5A
Target Class: ATPases Disease Areas: Cancer Site: Stockholm Status: Official |
||
HSPA6A
Target Class: ATPases Disease Areas: Cancer Site: Stockholm Status: Official |
||
PP-GNPNAT1
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||
PP-PMM
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||
CHKA
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
LOC390245C
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Oxford Status: Official |
||
PP-CDPK8
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
SETMAR
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
CHKA
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||
CBX1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
CRYL1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Official |
||
GSG2A
Target Class: Protein Kinase Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
SPSB1A
Target Class: SOCS-box-containing, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Oxford Status: Pending Not counted |
||
CAMK2DA
Target Class: Protein Kinase Disease Areas: Metabolism, Signalling, Neurobiology Site: Oxford Status: Official |
||
NUMBLA
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Stockholm Status: Official |
||
PP-GGPPS
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
LOC148158A
Target Class: Miscellaneous Disease Areas: Metabolism, Drug metabolism and toxicology Site: Oxford Status: Official |
||
DDX19A
Target Class: ATPases Disease Areas: Cancer Site: Stockholm Status: Official |
||
ACBD7A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Official |
||
LOC148158A
Target Class: Miscellaneous Disease Areas: Metabolism, Drug metabolism and toxicology Site: Oxford Status: Official |
||
PRDM12
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
SKILA
Target Class: Signalling proteins Disease Areas: Cancer Site: Stockholm Status: Official |
||
HMGCS2A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending |
||
XX03GNAI3A
Target Class: GTPases Disease Areas: Neurobiology Site: Oxford Status: Official |
||
RNMT
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
DNMT1
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
CTPS2A
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Follow-up official |
||
PP-PGAM2
Target Class: Isomerases, Transferases Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
GFPT1A
Target Class: Amino oxidases Disease Areas: Site: Stockholm Status: Official |
||
GNE
Target Class: Non-protein Kinase Disease Areas: Metabolism, Cancer Site: Toronto Status: Official |
||
NET1
Target Class: G-Protein Regulators Disease Areas: Cancer, Neurobiology Site: Toronto Status: Official |
||
PP-PYRK1
Target Class: Non-protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
SPSB2A
Target Class: SOCS-box-containing, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Official |
||
PCYT2A
Target Class: AA metabolic enzymes Disease Areas: Cancer Site: Stockholm Status: Official |
||
PGDA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending |
||
MAP1LC3A
Target Class: Ubiquitin Related Biology Disease Areas: Site: Toronto Status: Official |
||
PCCAA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Official |
||
FLJ10324A
Target Class: Cell-type specific expression Disease Areas: Site: Stockholm Status: Official |
||
PPPDE1
Target Class: Deubiquitinating Enzymes - Non-USP, Ubiquitin Related Biology Disease Areas: Site: Toronto Status: Official |
||
PLAP
Target Class: Ubiquitin Related Biology Disease Areas: Neurobiology Site: Toronto Status: Official |
||
ARHGAP11AA
Target Class: GTPases Disease Areas: Signalling, Neurobiology Site: Toronto Status: Official |
||
PP-GSK3
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
HDGF2
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
SPSB1A
Target Class: SOCS-box-containing, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Oxford Status: Official |
||
PP-UBC13
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
GSG2A
Target Class: Protein Kinase Disease Areas: Chromatin and epigenetics Site: Oxford Status: Official |
||
PTK9LA
Target Class: Signalling proteins Disease Areas: Signalling Site: Oxford Status: Official |
||
SERCA
Target Class: AA metabolic enzymes Disease Areas: Cancer Site: Stockholm Status: Official |
||
DDB1
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
EPHA3
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up official |
||
C6ORF197
Target Class: G-Protein Regulators Disease Areas: Site: Toronto Status: Pending |
||
LOC148158A
Target Class: Miscellaneous Disease Areas: Metabolism, Drug metabolism and toxicology Site: Oxford Status: Official |
||
FHA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Official |
||
TAX1BP3A
Target Class: Linkers Disease Areas: Signalling Site: Oxford Status: Official |
||
CAMK2AA
Target Class: Protein Kinase Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
PP-ROP2A
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
RAB3B
Target Class: GTPases Disease Areas: Cancer, Signalling Site: Toronto Status: Pending |
||
ATTYA
Target Class: AA metabolic enzymes Disease Areas: Site: Stockholm Status: Official |
||
PP-CDPK1
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
CREBBPA
Target Class: Bromodomain Disease Areas: Epigenetics Site: Oxford Status: Official |
||
ARFGAP1
Target Class: G-Protein Regulators Disease Areas: Cancer, Neurobiology Site: Toronto Status: Pending |
||
GMPSA
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
DYRK1AA
Target Class: Protein Kinase Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
GSG2A
Target Class: Protein Kinase Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Official |
||
ECHDC3A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Official |
||
OXCTA
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Official |
||
CBX3
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
LNX2A
Target Class: Linkers Disease Areas: Neurobiology Site: Oxford Status: Pending |
||
SETDB1
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
ubc81
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Pending Not counted |
||
CYP2R1
Target Class: Miscellaneous Disease Areas: Metabolism Site: Toronto Status: Follow-up official |
||
DDX52A
Target Class: ATPases Disease Areas: Cancer Site: Stockholm Status: Official |
||
EPHA7
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up official |
||
HECTD1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||
DEADC1A
Target Class: Nucleotide metabolism Disease Areas: Site: Stockholm Status: Official |
||
cgd3_920
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
RRM2BA
Target Class: Nucleotide metabolism Disease Areas: Metabolism, Cancer Site: Stockholm Status: Official |
||
L3MBTL2
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
GSG2A
Target Class: Protein Kinase Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Official |
||
CYP7A1
Target Class: Miscellaneous Disease Areas: Metabolism Site: Toronto Status: Official |
||
LOC148158A
Target Class: Miscellaneous Disease Areas: Metabolism, Drug metabolism and toxicology Site: Oxford Status: Official |
||
ATAD2A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Official |
||
UHRF1
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Toronto Status: Official |
||
UHRF1
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Toronto Status: Official |
||
PRDM1
Target Class: Transferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Pending |
||
PRDM4
Target Class: Transferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Pending |
||
CA13A
Target Class: Miscellaneous Disease Areas: Metabolism, Signalling Site: Oxford Status: Official |
||
cgd7_4270
Target Class: Isomerases, Transferases Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
GCN5L2A
Target Class: Bromodomain Disease Areas: Epigenetics Site: Oxford Status: Official |
||
ALOX12A
Target Class: Miscellaneous Disease Areas: Cancer Site: Stockholm Status: Official |
||
DUSP16A
Target Class: Phosphatases Disease Areas: Signalling Site: Oxford Status: Official |
||
EPHA2
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Official |
||
PDZK1A
Target Class: Linkers Disease Areas: Metabolism, Signalling Site: Oxford Status: Official |
||
GLSA
Target Class: AA metabolic enzymes Disease Areas: Cancer Site: Stockholm Status: Official |
||
RHPN2A
Target Class: Linkers Disease Areas: Site: Oxford Status: Official |
||
CYP2R1
Target Class: Miscellaneous Disease Areas: Metabolism Site: Toronto Status: Follow-up official |
||
LOC493869A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Official |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
CHN1
Target Class: G-Protein Regulators Disease Areas: Neurobiology Site: Toronto Status: Pending |
||
PFI0790w
Target Class: Oxidoreductases Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
NR1D2
Target Class: Miscellaneous Disease Areas: Metabolism, Cancer, Drug metabolism and toxicology Site: Toronto Status: Official |
||
cgd6_3790
Target Class: Oxidoreductases Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
ADH4A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Official |
||
ECH1A
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Official |
||
eif5a
Target Class: G-Protein Regulators Disease Areas: Cancer Site: Toronto Status: Pending |
||
FDPSA
Target Class: Miscellaneous Disease Areas: Metabolism, Signalling Site: Oxford Status: Official |
||
PTPREA
Target Class: Phosphatases Disease Areas: Metabolism, Signalling, Neurobiology Site: Oxford Status: Official |
||
NUDT16A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Cancer Site: Stockholm Status: Official |
||
CTHA
Target Class: AA metabolic enzymes Disease Areas: Metabolism, Neurobiology Site: Stockholm Status: Follow-up official |
||
NRASA
Target Class: GTPases Disease Areas: Cancer, Signalling Site: Toronto Status: Pending |
||
CBX4
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
DHPA
Target Class: Oxidoreductases Disease Areas: Drug metabolism and toxicology Site: Stockholm Status: Official |
||
UHRF1
Target Class: Ubiquitin Related Biology Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Toronto Status: Official |
||
PFB0500c
Target Class: GTPases Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
METTL1
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
SULT1b1
Target Class: Transferases Disease Areas: Metabolism, Cancer, Drug metabolism and toxicology Site: Toronto Status: Official |
||
MYNNA
Target Class: BTB-Kelch Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
birc6a
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Cancer, Signalling Site: Toronto Status: Official |
||
TTKA
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
GMPSA
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
PTPN4A
Target Class: Linkers Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
KLHL12A
Target Class: BTB-Kelch, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Oxford Status: Official |
||
KLC2
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Toronto Status: Pending |
||
L3MBTL2
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
PARP3A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
59.m03510
Target Class: Lipid signalling Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
FESA
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
Pv-PF11_0295
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
CBX7
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
PTK2BA
Target Class: Protein Kinase Disease Areas: Metabolism Site: Stockholm Status: Official |
||
FLJ38964A
Target Class: GTPases Disease Areas: Metabolism, Signalling Site: Toronto Status: Pending |
||
FESA
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
EPHA2
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Official |
||
SMS
Target Class: Transferases Disease Areas: Neurobiology Site: Toronto Status: Follow-up official |
||
GRLF1
Target Class: GTPases Disease Areas: Cancer Site: Toronto Status: Pending |
||
HDAC6
Target Class: Ubiquitin Related Biology Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
LOC148158A
Target Class: Miscellaneous Disease Areas: Metabolism, Drug metabolism and toxicology Site: Oxford Status: Follow-up official |
||
RASL12A
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Pending |
||
RTN4IP1A
Target Class: Oxidoreductases Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
ZADH1A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
CAMK2DA
Target Class: Protein Kinase Disease Areas: Metabolism, Signalling, Neurobiology Site: Oxford Status: Official |
||
Pkn-PF14_0020
Target Class: Non-protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
TULP1A
Target Class: Phosphoinosotide dependent signalling Disease Areas: Neurobiology Site: Stockholm Status: Follow-up not counted |
||
PARP3A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
PARP3A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Follow-up not counted |
||
BCL2A1A
Target Class: Apoptosis Disease Areas: Cancer, Signalling, Neurobiology Site: Stockholm Status: Official |
||
BIRC1A
Target Class: Apoptosis Disease Areas: Cancer, Signalling, Neurobiology Site: Stockholm Status: Official |
||
ubc47
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
OTUB1
Target Class: Deubiquitinating Enzymes - Non-USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
ARHGAP15A
Target Class: GTPases Disease Areas: Signalling Site: Oxford Status: Pending |
||
33.m00005
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
CTPS2A
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
BTBD6A
Target Class: BTB-Kelch, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Official |
||
NT5C3A
Target Class: Phosphatases Disease Areas: Metabolism Site: Stockholm Status: Follow-up not counted |
||
axl2
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up not counted |
||
DAPK3A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
MAGI1A@6
Target Class: Linkers Disease Areas: Neurobiology Site: Oxford Status: Official |
||
HIBCHA
Target Class: Miscellaneous Disease Areas: Metabolism, Neurobiology Site: Oxford Status: Official |
||
axl2
Human MER kinase domain in complex with 2-(2-hydroxyethylamino)-6-(3-chloroanilino)-9isopropylpurine Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Pending |
||
eif3s1
Target Class: G-Protein Regulators Disease Areas: Cancer Site: Toronto Status: Official |
||
SETMAR
Target Class: Transferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Official |
||
541.m00136
Target Class: Ubiquitin Related Biology Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
EIF4A2
Target Class: G-Protein Regulators Disease Areas: Site: Toronto Status: Pending |
||
PARP15A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Official |
||
49.m03261
Target Class: Isomerases Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
FESA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
ACADSA
Target Class: Oxidoreductases Disease Areas: Metabolism, Neurobiology Site: Oxford Status: Official |
||
NFATC2IP
Target Class: Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Pending |
||
SOCS6B
Target Class: SOCS-box-containing, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Metabolism, Signalling Site: Oxford Status: Official |
||
MUTA
Target Class: Miscellaneous Disease Areas: Metabolism, Neurobiology Site: Oxford Status: Official |
||
EPB41L3A
Target Class: Lipid signalling Disease Areas: Cancer Site: Stockholm Status: Follow-up official |
||
DAPK3A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
ubh12
Target Class: Ubiquitin Related Biology Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
THTPAA
Target Class: Phosphatases Disease Areas: Metabolism Site: Stockholm Status: Official |
||
CAMK2BA
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Official |
||
RNMT
Target Class: Transferases Disease Areas: Cancer Site: Toronto Status: Official |
||
KIF22
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending |
||
MALT1
Target Class: Proteases Disease Areas: Cancer Site: Toronto Status: Official |
||
PF13_0119
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Pending |
||
DDX47A
Target Class: ATPases Disease Areas: Cancer Site: Stockholm Status: Official |
||
PF10_0086
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
FDPSA
Target Class: Miscellaneous Disease Areas: Metabolism, Signalling Site: Oxford Status: Official |
||
FKBP06
Target Class: Isomerases Disease Areas: Signalling Site: Toronto Status: Official |
||
HKR3A
Target Class: BTB-Kelch Disease Areas: Site: Oxford Status: Official |
||
LOC148158A
Target Class: Miscellaneous Disease Areas: Metabolism, Drug metabolism and toxicology Site: Oxford Status: Official |
||
NEDD4
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling, Neurobiology Site: Toronto Status: Official |
||
PTPN11A
Target Class: Phosphatases Disease Areas: Site: Oxford Status: Official |
||
DDX20A
Target Class: ATPases Disease Areas: Neurobiology Site: Stockholm Status: Follow-up not counted |
||
PF11_0301
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
ACOT12BA
Target Class: Lipid signalling Disease Areas: Site: Stockholm Status: Official |
||
KIF3B
Target Class: Miscellaneous Disease Areas: Site: Toronto Status: Pending |
||
MDA5A
Target Class: ATPases Disease Areas: Cancer Site: Stockholm Status: Official |
||
Pv003920
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
KIF3C
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Toronto Status: Pending |
||
L3MBTL1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
L3MBTL1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
L3MBTL1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
L3MBTL1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
cgd6_3220
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
BRDTA
Target Class: Bromodomain Disease Areas: Epigenetics Site: Oxford Status: Official |
||
DMPK1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
JMJD2AA
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Oxford Status: Official |
||
EHMT1
Target Class: Transferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||
ASUCLA
Target Class: Nucleotide metabolism Disease Areas: Cancer, Neurobiology Site: Stockholm Status: Follow-up official |
||
TNKS1A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Official |
||
MAP3K10A
Target Class: Protein Kinase, Linkers Disease Areas: Site: Oxford Status: Official |
||
PLXNB1
Target Class: GTPases Disease Areas: Cancer Site: Toronto Status: Pending |
||
KIFC1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Official |
||
SULT1C3
Target Class: Transferases Disease Areas: Drug metabolism and toxicology Site: Toronto Status: Official |
||
EPHA7
Target Class: Protein Kinase Disease Areas: Cancer Site: Toronto Status: Official |
||
MAL13P1.284
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PFL0955c
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
STARD5A
Target Class: Lipid signalling Disease Areas: Cancer Site: Stockholm Status: Official |
||
MAGI1A@9
Target Class: Linkers Disease Areas: Neurobiology Site: Oxford Status: Official |
||
CLK1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
PTK9LA
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Official |
||
GPX3A
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Chromatin and epigenetics Site: Oxford Status: Official |
||
SUV39H2
Target Class: Transferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Official |
||
GARTA
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
EPHA5
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Official |
||
PLXNB1
Target Class: GTPases Disease Areas: Cancer Site: Toronto Status: Official |
||
GABARAPL1
Target Class: Ubiquitin Related Biology Disease Areas: Site: Toronto Status: Official |
||
PARC
Target Class: Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Official |
||
PFE1350c
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PDZD3A
Target Class: Linkers Disease Areas: Signalling Site: Oxford Status: Official |
||
SPG7A
Target Class: ATPases Disease Areas: Neurobiology Site: Stockholm Status: Official |
||
PFF0625w
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
CAMK2GA
Target Class: Protein Kinase Disease Areas: Metabolism, Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
ACOT7A
Target Class: Lipid signalling Disease Areas: Metabolism Site: Stockholm Status: Official |
||
DHRS1A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Official |
||
TBC1D14
Target Class: GTPases Disease Areas: Site: Toronto Status: Official |
||
PRDM2
Target Class: Transferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Official |
||
EPHA3
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up not counted |
||
EPHA3
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up not counted |
||
EPHA3
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up not counted |
||
PFB0395w
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
EPHA3
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up not counted |
||
EPHA3
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up not counted |
||
EPHA3
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up not counted |
||
EPHA3
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Follow-up not counted |
||
Nedd5
Target Class: GTPases Disease Areas: Cancer Site: Toronto Status: Pending |
||
XX04RAC3A
Target Class: GTPases Disease Areas: Cancer, Neurobiology Site: Oxford Status: Official |
||
VRK2A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
cgd5_2510
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
EPHB4
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Official |
||
GARTA
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
FDPSA
Target Class: Miscellaneous Disease Areas: Metabolism, Cancer, Signalling Site: Oxford Status: Pending |
||
CSADA
Target Class: AA metabolic enzymes Disease Areas: Cancer Site: Stockholm Status: Official |
||
ubc64
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Cancer Site: Toronto Status: Official |
||
JARID1CA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics, Neurobiology Site: Oxford Status: Pending |
||
SMS
Target Class: Transferases Disease Areas: Neurobiology Site: Toronto Status: Official |
||
cgd7_1840
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Pv-PF11_0257
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
SYNJ2BPA
Target Class: Linkers Disease Areas: Signalling Site: Oxford Status: Official |
||
SYNJ2BPA
Target Class: Linkers Disease Areas: Signalling Site: Oxford Status: Follow-up not counted |
||
UGDHA
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
VRK3A
Target Class: Protein Kinase Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
GRIP1A
Target Class: Linkers Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
MPDZA@11
Target Class: Linkers Disease Areas: Cancer, Neurobiology Site: Oxford Status: Official |
||
PY06285
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PFB0295w
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Pending Not counted |
||
C22orf4
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
capn08
Target Class: Proteases Disease Areas: Neurobiology Site: Toronto Status: Official |
||
PTPRN2A
Target Class: Phosphatases Disease Areas: Neurobiology, Signalling, Metabolism Site: Oxford Status: Official |
||
ADSS2A
Target Class: Nucleotide metabolism Disease Areas: Cancer, Drug metabolism and toxicology Site: Stockholm Status: Official |
||
cgd2_1660
Target Class: Isomerases Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
GLULA
Target Class: AA metabolic enzymes Disease Areas: Metabolism, Neurobiology Site: Stockholm Status: Not counted |
||
MAGI1A@7
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Official |
||
NUDT3A
Target Class: Phosphatases, NUDIX Disease Areas: Signalling Site: Stockholm Status: Pending Not counted |
||
PF10_0225
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
UMPSA
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Pending Not counted |
||
SPSB4A
Target Class: SOCS-box-containing, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Official |
||
PDLIM4A
Target Class: Miscellaneous Disease Areas: Neurobiology, Cancer, Signalling Site: Oxford Status: Official |
||
PDLIM7A
Target Class: Miscellaneous Disease Areas: Metabolism, Signalling Site: Oxford Status: Official |
||
RECQLA
Target Class: Disease Areas: Cancer Site: Oxford Status: Official |
||
RHOUA
Target Class: GTPases Disease Areas: Signalling, Cancer Site: Oxford Status: Official |
||
UGDHA
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Signalling, Neurobiology, Drug metabolism and toxicology Site: Oxford Status: Official |
||
cgd2_1800
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
RRAGD
Target Class: GTPases Disease Areas: Cancer Site: Toronto Status: Official |
||
PAK4A
Target Class: Non-protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
PFC0255c
Target Class: Malaria, Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
MGC2408
Target Class: Transferases Disease Areas: Site: Toronto Status: Official |
||
PF11_0301
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PY01609
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Pending Not counted |
||
MYST1
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
HDAC7
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
HDAC7
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
NAT1
human N-acetyltransferase 1 (arylamine N-acetyltransferase) with S-(2-anilino-2-oxoethyl)-L-cysteine Target Class: Transferases Disease Areas: Metabolism, Cancer, Drug metabolism and toxicology Site: Toronto Status: Follow-up not counted |
||
PF11_0301
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
PF11_0301
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
STARD13A
Target Class: Lipid signalling Disease Areas: Cancer Site: Stockholm Status: Official |
||
PF11_0301
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
MAK3
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
L3MBTL1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
PARP12A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Official |
||
DUSP13F
Target Class: Phosphatases Disease Areas: Signalling Site: Oxford Status: Official |
||
LIPR
Target Class: Miscellaneous Disease Areas: Metabolism Site: Toronto Status: Official |
||
PRKCGA@3
Target Class: Protein Kinase Disease Areas: Neurobiology, Cancer, Signalling Site: Oxford Status: Official |
||
GANA
Target Class: BTB-Kelch, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Neurobiology Site: Oxford Status: Official |
||
PDLIM5A
Target Class: Miscellaneous Disease Areas: Signalling, Neurobiology, Cancer Site: Oxford Status: Official |
||
cgd2_4120
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
GUADA
Target Class: Nucleotide metabolism Disease Areas: Signalling Site: Stockholm Status: Official |
||
cgd2_1660
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
IDI2
Target Class: Diabetes Disease Areas: Metabolism Site: Toronto Status: Official |
||
GRASPA
Target Class: Linkers Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
PRDX4A
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism Site: Oxford Status: Official |
||
KRASB
Target Class: GTPases Disease Areas: Cancer, Signalling Site: Toronto Status: Official |
||
RASEF
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
PF13_0052
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
cgd2_4120
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
NPACA
Target Class: Oxidoreductases Disease Areas: Signalling Site: Oxford Status: Official |
||
DDX10A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Stockholm Status: Official |
||
KIAA0089A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
SPRED2A
Target Class: Signalling proteins Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
PDLIM1A
Target Class: Linkers Disease Areas: Cancer Site: Oxford Status: Official |
||
NAT2
Target Class: Transferases Disease Areas: Metabolism, Drug metabolism and toxicology, Cancer Site: Toronto Status: Official |
||
Cp-PFA0230c
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
HSD17B8A
Target Class: Oxidoreductases Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
ACADVLA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
FKBP02
Target Class: Isomerases Disease Areas: Signalling Site: Toronto Status: Official |
||
PF14_0309
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PDLIM2B
Target Class: Linkers Disease Areas: Cancer Site: Oxford Status: Official |
||
PTPN9A
Target Class: Phosphatases Disease Areas: Metabolism, Cancer, Signalling Site: Oxford Status: Official |
||
PARP3A
Target Class: Poly ADP-ribose polymerase Disease Areas: Cancer Site: Stockholm Status: Official |
||
CAMK2GA
Target Class: Protein Kinase Disease Areas: Neurobiology, Cancer, Signalling, Metabolism Site: Oxford Status: Official |
||
HMGCS1A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
APG4A
Target Class: Proteases Disease Areas: Metabolism, Cancer, Neurobiology Site: Toronto Status: Official |
||
DDX41A
Target Class: DExD-DExH RNA helicases Disease Areas: Site: Stockholm Status: Official |
||
PTPN22A
Target Class: Phosphatases Disease Areas: Metabolism, Cancer, Signalling Site: Oxford Status: Official |
||
pv089580
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
RASEF
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
ASMTL
Target Class: Transferases Disease Areas: Neurobiology, Cancer Site: Toronto Status: Official |
||
ZNF289
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
UCK1A
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Pending Not counted |
||
BIRC3A
Target Class: Apoptosis Disease Areas: Cancer Site: Stockholm Status: Official |
||
GPX7A
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism Site: Oxford Status: Official |
||
PY03671
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Pending Not counted |
||
HAT1
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
CAPN09
Target Class: Proteases Disease Areas: Signalling, Cancer Site: Toronto Status: Follow-up official |
||
C9orf95
Target Class: Non-protein Kinase Disease Areas: Metabolism, Drug metabolism and toxicology Site: Toronto Status: Official |
||
SCMH1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
mertk
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Toronto Status: Official |
||
SYN3A
Target Class: Vesicle Transport Disease Areas: Neurobiology Site: Oxford Status: Official |
||
ACADSBA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
MYST3
Target Class: Transferases Disease Areas: Epigenetics Site: Toronto Status: Official |
||
SLC9A3R1A
Target Class: Linkers Disease Areas: Cancer Site: Oxford Status: Official |
||
PRPSAP2A
Target Class: Nucleotide metabolism Disease Areas: Neurobiology, Cancer, Signalling Site: Stockholm Status: Official |
||
DDX20A
Target Class: DExD-DExH RNA helicases Disease Areas: Neurobiology Site: Stockholm Status: Official |
||
LIPS
Target Class: Miscellaneous Disease Areas: Metabolism Site: Toronto Status: Official |
||
JMJD2AA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics, Cancer Site: Oxford Status: Follow-up not counted |
||
UMPSA
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
Cp-PF08_0120
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
RACGAP1A
Target Class: GTPases Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
BRD4A@2
Target Class: Bromodomain Disease Areas: Signalling, Chromatin and epigenetics, Cancer Site: Oxford Status: Official |
||
XX01RAC3A
Target Class: GTPases Disease Areas: Neurobiology, Signalling, Cancer Site: Oxford Status: Official |
||
HTATIP
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
NT5C3A
Target Class: Phosphatases Disease Areas: Metabolism Site: Stockholm Status: Pending Not counted |
||
JMJD2AA
Target Class: Oxidoreductases Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Signalling, Chromatin and epigenetics Site: Oxford Status: Official |
||
CHN1
Target Class: GTPases Disease Areas: Neurobiology Site: Toronto Status: Official |
||
JMJD2AA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics, Cancer Site: Oxford Status: Follow-up not counted |
||
FASNA
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer Site: Oxford Status: Official |
||
RGS14A
Target Class: G-Protein Regulators Disease Areas: Signalling Site: Oxford Status: Official |
||
SLKA
Target Class: Protein Kinase Disease Areas: Signalling, Cancer Site: Oxford Status: Official |
||
SLKA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
Cp-PF11_0447
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
FASNA
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism Site: Oxford Status: Official |
||
JMJD2AA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics, Cancer Site: Oxford Status: Official |
||
JMJD2AA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics, Cancer Site: Oxford Status: Follow-up not counted |
||
PHYD1B
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
MPDZA@10
Target Class: Linkers Disease Areas: Neurobiology, Cancer Site: Oxford Status: Official |
||
PTPRTA
Target Class: Phosphatases Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
BRD3A@2
Target Class: Bromodomain Disease Areas: Cancer, Signalling and epigenetics Site: Oxford Status: Official |
||
NEDD4L
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling, Neurobiology Site: Toronto Status: Official |
||
PF10_0330
Target Class: Malaria, Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
CTBP2A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
CYP2R1
Target Class: Miscellaneous Disease Areas: Metabolism Site: Toronto Status: Official |
||
HRB
Target Class: GTPases Disease Areas: Cancer, Signalling Site: Toronto Status: Official |
||
UCK1A
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
GLULA
Target Class: AA metabolic enzymes Disease Areas: Neurobiology, Metabolism Site: Stockholm Status: Official |
||
RAB25
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
BAK1A
Target Class: Apoptosis Disease Areas: Cancer, Neurobiology Site: Stockholm Status: Official |
||
NT5C2A
Target Class: Phosphatases Disease Areas: Metabolism, Cancer Site: Stockholm Status: Pending Not counted |
||
ITPK1A
Target Class: Phosphoinosotide dependent signalling Disease Areas: Signalling Site: Stockholm Status: Official |
||
XX02RGS8A
Target Class: G-Protein Regulators Disease Areas: Neurobiology, Signalling, Cancer, Metabolism Site: Oxford Status: Official |
||
XX03CDC42A
Target Class: Protein Kinase Disease Areas: Signalling, Cancer Site: Oxford Status: Official |
||
NT5C2A
Target Class: Phosphatases Disease Areas: Cancer, Metabolism Site: Stockholm Status: Pending Not counted |
||
SLC9A3R2A
Target Class: Linkers Disease Areas: Signalling Site: Oxford Status: Official |
||
MAT1A
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer Site: Oxford Status: Official |
||
PTPN18A
Target Class: Phosphatases Disease Areas: Neurobiology, Signalling, Cancer Site: Oxford Status: Official |
||
RAB9B
Target Class: GTPases Disease Areas: Neurobiology Site: Toronto Status: Official |
||
CAMK1DA
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
MAK3
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
UBC54
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
BAT8
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
cgd7_2470
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PRTFDC1A
Target Class: Nucleotide metabolism Disease Areas: Metabolism Site: Stockholm Status: Official |
||
RAB4B
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
MPDZA
Target Class: Linkers Disease Areas: Cancer, Neurobiology Site: Oxford Status: Official |
||
MAP2K5A
Target Class: Protein Kinase Disease Areas: Signalling, Metabolism, Cancer Site: Oxford Status: Official |
||
cgd4_2550
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
CAMK1GA
Target Class: Protein Kinase Disease Areas: Neurobiology, Signalling Site: Oxford Status: Official |
||
HADH2A
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Neurobiology Site: Oxford Status: Follow-up not counted |
||
PPP2R5CA
Target Class: Phosphatases Disease Areas: Signalling, Cancer, Neurobiology Site: Stockholm Status: Official |
||
Pv-PF14_0053
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
UBC32
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
SRM
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Follow-up official |
||
HK2
Target Class: Non-protein Kinase Disease Areas: Cancer, Metabolism Site: Toronto Status: Official |
||
FTSJ2
Target Class: Transferases Disease Areas: Site: Toronto Status: Official |
||
HAO1A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
REM1A
Target Class: GTPases Disease Areas: Signalling, Cancer Site: Oxford Status: Official |
||
ASSA
Target Class: AA metabolic enzymes Disease Areas: Metabolism Site: Stockholm Status: Official |
||
PTPRJA
Target Class: Phosphatases Disease Areas: Signalling, Cancer Site: Oxford Status: Follow-up not counted |
||
BRD3A
Target Class: Bromodomain Disease Areas: Signalling, Cancer and epigenetics Site: Oxford Status: Official |
||
SLKA
Target Class: Protein Kinase Disease Areas: Signalling, Cancer Site: Oxford Status: Follow-up not counted |
||
NEDD4L
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling, Neurobiology Site: Toronto Status: Official |
||
KIF9
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Official |
||
DAPK3A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
TP53I3A
Target Class: Oxidoreductases Disease Areas: Cancer Site: Oxford Status: Official |
||
CAPN08a
Target Class: Proteases Disease Areas: Signalling, Cancer Site: Toronto Status: Official |
||
MAP2K5A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
ITCH
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||
CPSF5A
Target Class: Nucleotide metabolism Disease Areas: Metabolism Site: Stockholm Status: Follow-up not counted |
||
cgd3_1290
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
CTHA
Target Class: AA metabolic enzymes Disease Areas: Metabolism Site: Stockholm Status: Official |
||
PTPRGA
Target Class: Phosphatases Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
ASUCLA
Target Class: Nucleotide metabolism Disease Areas: Cancer, Neurobiology Site: Stockholm Status: Official |
||
STK10A
Target Class: Protein Kinase Disease Areas: Signalling, Cancer Site: Oxford Status: Official |
||
LOC64744
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
RGS16A
Target Class: G-Protein Regulators Disease Areas: Metabolism, Signalling, Neurobiology Site: Oxford Status: Official |
||
cgd1_2980
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
ALDH7A1A
Target Class: Oxidoreductases Disease Areas: Neurobiology, Metabolism Site: Oxford Status: Official |
||
NAT1
Target Class: Transferases Disease Areas: Cancer, Drug metabolism and toxicology, Metabolism Site: Toronto Status: Official |
||
NNMT
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
TLR10A
Target Class: Signalling proteins Disease Areas: Parasitic disease Site: Stockholm Status: Official |
||
RGS10A
Target Class: G-Protein Regulators Disease Areas: Neurobiology, Metabolism, Signalling Site: Oxford Status: Official |
||
Pv-PF11_0295
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
ACAA1A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
BACH1A
Target Class: BTB-Kelch Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
RGS8A
Target Class: G-Protein Regulators Disease Areas: Signalling, Neurobiology, Cancer Site: Oxford Status: Official |
||
EHMT1
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
CHKB
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
RAC3A
Target Class: GTPases Disease Areas: Signalling, Neurobiology, Cancer Site: Oxford Status: Follow-up not counted |
||
ALDRL6A
Target Class: Oxidoreductases Disease Areas: Signalling, Metabolism Site: Stockholm Status: Official |
||
USP02
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
SLKA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
HIBADHA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
CHKA
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Toronto Status: Official |
||
PANK1
Target Class: Non-protein Kinase Disease Areas: Neurobiology, Metabolism Site: Toronto Status: Official |
||
PANK3
Target Class: Non-protein Kinase Disease Areas: Neurobiology, Metabolism Site: Toronto Status: Official |
||
Pv-PF14_0368
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
PTPN4A
Target Class: Phosphatases Disease Areas: Neurobiology, Signalling Site: Oxford Status: Official |
||
PF11_0301
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
MAPK6A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
ubc81
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
ITPAA
Target Class: Phosphatases Disease Areas: Metabolism, Cancer Site: Stockholm Status: Follow-up official |
||
mNNMT
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Follow-up not counted |
||
HDAC7A
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
RGS10A
Target Class: G-Protein Regulators Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
DDX3XA
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Stockholm Status: Official |
||
GPX5A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
NT5C2A
Target Class: Phosphatases Disease Areas: Metabolism, Cancer Site: Stockholm Status: Official |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
DLG3A
Target Class: Linkers Disease Areas: Signalling Site: Oxford Status: Official |
||
RHODA
Target Class: GTPases Disease Areas: Signalling Site: Oxford Status: Official |
||
PAK4A
Target Class: Non-protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
PHPT1A
Target Class: Phosphatases Disease Areas: Signalling Site: Stockholm Status: Official |
||
PYCR1A
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism Site: Oxford Status: Official |
||
ECHS1A
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer Site: Oxford Status: Official |
||
Pv-PFB0295w
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
GNPNAT1
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
GNPNAT1
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Follow-up not counted |
||
CSNK1G3A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
CSNK1G3A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
CSNK1G3A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
CSNK1G3A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
XX02SOCS4B
Target Class: SOCS-box-containing, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Oxford Status: Official |
||
GLRX2A
Target Class: Oxidoreductases Disease Areas: Neurobiology, Metabolism Site: Oxford Status: Official |
||
PF11_0301
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
CBR3A
Target Class: Oxidoreductases Disease Areas: Neurobiology, Cancer, Metabolism, Drug metabolism and toxicology Site: Oxford Status: Official |
||
PPI70
Target Class: Isomerases Disease Areas: Cancer, Signalling Site: Toronto Status: Official |
||
RRM2A
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
KHK
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
CENTG1A
Target Class: GTPases Disease Areas: Signalling, Neurobiology, Cancer Site: Oxford Status: Follow-up not counted |
||
MPDZA
Target Class: Linkers Disease Areas: Cancer, Neurobiology Site: Oxford Status: Official |
||
MPDZA
Target Class: Linkers Disease Areas: Cancer, Neurobiology Site: Oxford Status: Official |
||
MPDZA
Target Class: Linkers Disease Areas: Cancer, Neurobiology Site: Oxford Status: Follow-up not counted |
||
MPDZA
Target Class: Linkers Disease Areas: Cancer, Neurobiology Site: Oxford Status: Follow-up not counted |
||
cgd7_470
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
MAT2AA
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism Site: Oxford Status: Official |
||
PIM2A
Target Class: Protein Kinase Disease Areas: Signalling, Cancer Site: Oxford Status: Official |
||
KIF2C
Target Class: Miscellaneous Disease Areas: Neurobiology, Cancer Site: Toronto Status: Official |
||
PPI63
Target Class: Isomerases Disease Areas: Signalling Site: Toronto Status: Official |
||
RAB5B
Target Class: GTPases Disease Areas: Neurobiology Site: Toronto Status: Official |
||
SCLYA
Target Class: AA metabolic enzymes Disease Areas: Metabolism Site: Stockholm Status: Official |
||
SLC9A3R2A
Target Class: Linkers Disease Areas: Signalling Site: Oxford Status: Official |
||
CCNT2A
Target Class: Miscellaneous Disease Areas: Signalling Site: Oxford Status: Official |
||
cgd4_2550
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
DLG2A
Target Class: Linkers Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
EPB41L3A
Target Class: Lipid signalling Disease Areas: Cancer Site: Stockholm Status: Official |
||
GPX2A
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer Site: Oxford Status: Official |
||
TARBP1
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
WDR5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
WDR5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
WDR5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
WDR5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
WDR5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
SULT1C3
Target Class: Transferases Disease Areas: Drug metabolism and toxicology, Metabolism Site: Toronto Status: Pending Not counted |
||
AMPKA2
Target Class: Protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
BLVRAA
Target Class: Oxidoreductases Disease Areas: Cancer, Drug metabolism and toxicology, Signalling, Metabolism Site: Oxford Status: Official |
||
Pv-PF14_0368
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Not counted |
||
PYCSA
Target Class: Oxidoreductases Disease Areas: Metabolism, Neurobiology, Signalling Site: Oxford Status: Official |
||
ARL6
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
KIFC3
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Official |
||
PTPRGA
Target Class: Phosphatases Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
THEM2A
Target Class: Lipid signalling Disease Areas: Signalling, Neurobiology Site: Stockholm Status: Official |
||
RGS18A
Target Class: G-Protein Regulators Disease Areas: Signalling Site: Oxford Status: Official |
||
MAL13P1.227
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Not counted |
||
NT5C3A
Target Class: Phosphatases Disease Areas: Metabolism Site: Stockholm Status: Official |
||
ARL5
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||
PF14_0156
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
ARL5
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||
ARL10B
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||
CSNK1G1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
MGC3329
Target Class: Transferases Disease Areas: Site: Toronto Status: Official |
||
PRKCABPA
Target Class: Linkers Disease Areas: Neurobiology Site: Oxford Status: Official |
||
SULT1C2
Target Class: Transferases Disease Areas: Drug metabolism and toxicology, Metabolism Site: Toronto Status: Follow-up official |
||
USP08
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
Pv-PF10_0225
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
AKR7A3A
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism, Drug metabolism and toxicology Site: Oxford Status: Official |
||
CDYL
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
MAP3K5A
Target Class: Protein Kinase Disease Areas: Neurobiology, Signalling Site: Oxford Status: Official |
||
RND1A
Target Class: GTPases Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
XX01RGS1A
Target Class: G-Protein Regulators Disease Areas: Metabolism, Neurobiology, Signalling, Cancer Site: Oxford Status: Official |
||
DRP2A
Target Class: Oxidoreductases Disease Areas: Neurobiology Site: Stockholm Status: Official |
||
EPHA3
Target Class: Protein Kinase Disease Areas: Signalling, Cancer Site: Toronto Status: Official |
||
CPSF5A
Target Class: Nucleotide metabolism Disease Areas: Metabolism Site: Stockholm Status: Official |
||
GPX4A
Target Class: Oxidoreductases Disease Areas: Drug metabolism and toxicology, Neurobiology, Metabolism Site: Oxford Status: Official |
||
KIF2
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Toronto Status: Official |
||
NEK2A
Target Class: Protein Kinase Disease Areas: Signalling, Cancer Site: Oxford Status: Official |
||
PTPN5A
Target Class: Phosphatases Disease Areas: Neurobiology, Signalling Site: Oxford Status: Official |
||
WDR5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
RXRG
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics, Cancer Site: Toronto Status: Official |
||
CKMT2
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
PIP5K2CA
Target Class: Phosphoinosotide dependent signalling Disease Areas: Signalling Site: Stockholm Status: Official |
||
PTPROA
Target Class: Phosphatases Disease Areas: Signalling, Cancer, Neurobiology Site: Oxford Status: Official |
||
RRADA
Target Class: GTPases Disease Areas: Metabolism, Signalling, Cancer Site: Oxford Status: Official |
||
MYST1
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
PY06054
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
USP08
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
DIRASA
Target Class: GTPases Disease Areas: Signalling, Cancer Site: Oxford Status: Official |
||
HIBADHA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
RAB3D
Target Class: GTPases Disease Areas: Neurobiology Site: Toronto Status: Official |
||
HPGDA
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism, Signalling Site: Oxford Status: Official |
||
CSNK1G3A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
NR4A1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
SARA1
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
DDX2AA
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Stockholm Status: Official |
||
MDH2A
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer Site: Oxford Status: Official |
||
MALT1
Target Class: Proteases Disease Areas: Cancer, Signalling Site: Toronto Status: Official |
||
AASDHPPTA
Human holo-ACP synthase in complex with Coenzyme A and the ACP domain of cytosolic fatty acid syntha Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
PHGDHA
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Neurobiology Site: Oxford Status: Official |
||
TXNRD1A
Target Class: Oxidoreductases Disease Areas: Metabolism, Drug metabolism and toxicology, Cancer Site: Oxford Status: Official |
||
PPP2R4A
Target Class: Phosphatases Disease Areas: Cancer, Neurobiology, Signalling Site: Stockholm Status: Official |
||
RAB26
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
PTPRJA
Target Class: Phosphatases Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
GEMA
Target Class: GTPases Disease Areas: Neurobiology, Cancer Site: Oxford Status: Official |
||
FTHFDB
Target Class: Oxidoreductases Disease Areas: Cancer Site: Stockholm Status: Not counted |
||
DDX25A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Stockholm Status: Official |
||
KIF1C
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Official |
||
NRDP1
Target Class: Diabetes, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling, Diabetes Site: Toronto Status: Official |
||
RAC3A
Target Class: GTPases Disease Areas: Signalling, Neurobiology, Cancer Site: Oxford Status: Official |
||
SIRT5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
HRMT1L3
Target Class: Transferases Disease Areas: Site: Toronto Status: Official |
||
SAT
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Not counted |
||
Cp-PF14_0411
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
AKR1C4A
Target Class: Oxidoreductases Disease Areas: Signalling, Cancer, Drug metabolism and toxicology, Metabolism Site: Oxford Status: Official |
||
GGPS1A
Target Class: Oxidoreductases Disease Areas: Signalling, Metabolism Site: Oxford Status: Official |
||
IMPA2A
Target Class: Phosphoinosotide dependent signalling Disease Areas: Neurobiology, Signalling Site: Stockholm Status: Official |
||
NUDT3A
Target Class: Phosphatases, NUDIX Disease Areas: Signalling Site: Stockholm Status: Official |
||
PAK4A
Target Class: Protein Kinase Disease Areas: Signalling, Cancer, Neurobiology Site: Oxford Status: Follow-up not counted |
||
CDY
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Not counted |
||
RBKS
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
RHOBA
Target Class: GTPases Disease Areas: Signalling, Cancer Site: Oxford Status: Official |
||
PFE0505w
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Pv-MAL13P1.227
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
RAB1A
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
MPDZA
Target Class: Linkers Disease Areas: Neurobiology, Cancer Site: Oxford Status: Official |
||
RRASA
Target Class: GTPases Disease Areas: Neurobiology, Signalling, Cancer Site: Oxford Status: Official |
||
GLRX2A
Target Class: Oxidoreductases Disease Areas: Drug metabolism and toxicology, Neurobiology, Metabolism Site: Oxford Status: Official |
||
PKCH
Target Class: Protein Kinase Disease Areas: Signalling Site: Toronto Status: Official |
||
TULP1A
Target Class: Phosphoinosotide dependent signalling Disease Areas: Neurobiology Site: Stockholm Status: Official |
||
ITPAA
Target Class: Phosphatases Disease Areas: Cancer, Metabolism Site: Stockholm Status: Official |
||
RAB31
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
Pv-PF10_0225
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
AK2A
Target Class: Non-protein Kinase Disease Areas: Cancer, Metabolism, Signalling, Drug metabolism and toxicology Site: Oxford Status: Official |
||
DLG3A
Target Class: Linkers Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
PY00414
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PF10_0225
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Not counted |
||
XX10SOCS2A
Target Class: SOCS-box-containing Disease Areas: Neurobiology, Signalling, Cancer, Metabolism Site: Oxford Status: Official |
||
FLJ20604A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
MPDZA
Target Class: Linkers Disease Areas: Neurobiology, Cancer Site: Oxford Status: Official |
||
PFL2275c
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
AK1A
Target Class: Non-protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up not counted |
||
CDY1
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
ubh12
Target Class: Ubiquitin Related Biology Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Official |
||
GPX1A
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer Site: Oxford Status: Official |
||
RAB27B
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
FABP1A
Target Class: Lipid signalling Disease Areas: Metabolism Site: Stockholm Status: Official |
||
PECIA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
PFC0310c
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PTPRKA
Target Class: Phosphatases Disease Areas: Signalling, Cancer, Neurobiology Site: Oxford Status: Official |
||
RGS3A
Target Class: G-Protein Regulators Disease Areas: Neurobiology, Cancer, Signalling Site: Oxford Status: Official |
||
PAK5A
Target Class: Non-protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
TgTwinScan_2721
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
UBC57
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
YWHAHA
Target Class: Signalling proteins Disease Areas: Neurobiology, Signalling Site: Oxford Status: Follow-up not counted |
||
AMPKB2
Target Class: Protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
GMPR2A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Stockholm Status: Follow-up official |
||
CLK3A
Target Class: Protein Kinase Disease Areas: Neurobiology, Signalling Site: Oxford Status: Follow-up not counted |
||
AD-003
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
YWHAHA
Target Class: Signalling proteins Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
MAP3K3B
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Metabolism Site: Oxford Status: Official |
||
RAB30
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
CLK3A
Target Class: Protein Kinase Disease Areas: Neurobiology, Signalling Site: Oxford Status: Official |
||
CTPSA
Target Class: Nucleotide metabolism Disease Areas: Cancer Site: Stockholm Status: Official |
||
PPI66
Target Class: Isomerases Disease Areas: Signalling Site: Toronto Status: Official |
||
DIRAS2A
Target Class: GTPases Disease Areas: Signalling Site: Oxford Status: Official |
||
RGS6A
Target Class: G-Protein Regulators Disease Areas: Signalling, Neurobiology, Cancer Site: Oxford Status: Official |
||
RRAS2A
Target Class: GTPases Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
ACAT1
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
PAP39A
Target Class: Nucleotide metabolism Disease Areas: Metabolism Site: Stockholm Status: Official |
||
PY06285
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
AK3A
Target Class: Non-protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
CorA
Target Class: Membrane proteins Disease Areas: Site: Toronto Status: Official |
||
CSNK1G2A
Target Class: Protein Kinase Disease Areas: Signalling, Metabolism Site: Oxford Status: Official |
||
RNGTTA
Target Class: Phosphatases Disease Areas: Site: Oxford Status: Official |
||
AASDHPPTA
AASDHPPT: Human aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase in complex w Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
NSUN5
Target Class: Transferases Disease Areas: Site: Toronto Status: Official |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
PY00693
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PAK6A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
ARF5
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
UXS1A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
MTA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
RAC3A
Target Class: GTPases Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
YWHABA
Target Class: Signalling proteins Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
SIRT5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
PTPN3A
Target Class: Phosphatases Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
FLJ20628
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
Cp-PFA0260c
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
UPLC1
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
YWHAGA
Target Class: Signalling proteins Disease Areas: Cancer, Neurobiology, Signalling Site: Oxford Status: Official |
||
TgTwinScan_2218
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PAPSS2
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
FKBP08
Target Class: Isomerases Disease Areas: Signalling Site: Toronto Status: Official |
||
UBC36
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
PKN-PF08_0071
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Not counted |
||
ME1A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
COMTD1
Target Class: Transferases Disease Areas: Drug metabolism and toxicology, Metabolism Site: Toronto Status: Official |
||
MGC45594A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Official |
||
PY07357
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
RERGA
Target Class: GTPases Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
CAPN01
Target Class: Proteases Disease Areas: Signalling, Neurobiology Site: Toronto Status: Official |
||
AK3A
Target Class: Non-protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
TPMT
Target Class: Transferases Disease Areas: Metabolism, Cancer Site: Toronto Status: Official |
||
GMPR2A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Stockholm Status: Official |
||
PY01515
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up not counted |
||
PTPN14A
Target Class: Phosphatases Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
PY02076
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
ARL10C
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
PDXK
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
DLG2A
Target Class: Linkers Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
AASDHPPTA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
Cp-PF11_0250
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PTPRBA
Target Class: Phosphatases Disease Areas: Cancer Site: Oxford Status: Official |
||
DHRS6A
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
RGS2A
Target Class: G-Protein Regulators Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
RAB14
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
SULT1C2
Target Class: Transferases Disease Areas: Drug metabolism and toxicology, Metabolism Site: Toronto Status: Official |
||
AK5A
Target Class: Non-protein Kinase Disease Areas: Neurobiology, Signalling Site: Oxford Status: Official |
||
GMPRA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
USP08
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
ITPKCA
Target Class: Phosphoinosotide dependent signalling Disease Areas: Signalling Site: Stockholm Status: Official |
||
FTHFDA
Target Class: Oxidoreductases Disease Areas: Cancer Site: Stockholm Status: Official |
||
UBC22
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
SHMT2
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
RGS7A
Target Class: G-Protein Regulators Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
RAB2B
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
PY02252
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
UBC62
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
PTPN7A
Target Class: Phosphatases Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
PAK4A
Target Class: Protein Kinase Disease Areas: Signalling, Neurobiology, Cancer Site: Oxford Status: Official |
||
PPI60
Target Class: Isomerases Disease Areas: Signalling Site: Toronto Status: Official |
||
PTPN5A
Target Class: Phosphatases Disease Areas: Neurobiology, Signalling Site: Oxford Status: Follow-up not counted |
||
PHYHA
Target Class: Oxidoreductases Disease Areas: Metabolism, Signalling, Neurobiology Site: Oxford Status: Official |
||
Cp-PF14_0064
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
RGS1A
Target Class: G-Protein Regulators Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
INMT
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
STK16A
Target Class: Protein Kinase Disease Areas: Signalling, Cancer Site: Oxford Status: Official |
||
GAMT
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
NQO2A
Target Class: Oxidoreductases Disease Areas: Metabolism, Drug metabolism and toxicology, Cancer Site: Oxford Status: Official |
||
YWHAQA
Target Class: Signalling proteins Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
FDPSA
Human farnesyl diphosphate synthase in complex with zoledronate, isopentenyl pyrophosphate and magne Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Signalling Site: Oxford Status: Official |
||
RGS17A
Target Class: G-Protein Regulators Disease Areas: Signalling, Neurobiology, Cancer Site: Oxford Status: Official |
||
UBC63
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
CGI63A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Official |
||
KCNAB2B
Target Class: Oxidoreductases Disease Areas: Neurobiology Site: Oxford Status: Official |
||
LTB4DHA
Target Class: Oxidoreductases Disease Areas: Signalling, Cancer, Drug metabolism and toxicology Site: Oxford Status: Official |
||
RGS16A
Target Class: G-Protein Regulators Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
NME3
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
HS3ST1
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
HSA9761
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
Cp-PF14_0122
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
GAPDH
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Toronto Status: Official |
||
YWHAEA
Target Class: Signalling proteins Disease Areas: Cancer, Neurobiology, Metabolism, Signalling Site: Oxford Status: Official |
||
PPI65
Target Class: Isomerases Disease Areas: Signalling Site: Toronto Status: Official |
||
UBH20
Target Class: Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
PKM2
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
CAPN09
Target Class: Proteases Disease Areas: Signalling, Cancer Site: Toronto Status: Official |
||
YWHABA
Target Class: Signalling proteins Disease Areas: Signalling, Cancer, Neurobiology Site: Oxford Status: Official |
||
SULT1C1
Target Class: Transferases Disease Areas: Cancer, Metabolism Site: Toronto Status: Official |
||
PTPRRA
Target Class: Phosphatases Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
AKR7A2A
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism, Neurobiology, Drug metabolism and toxicology Site: Oxford Status: Official |
||
AK3L1
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
SRM
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
ARL10B
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
UBC52
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
ppi40
Target Class: Isomerases Disease Areas: Signalling Site: Toronto Status: Official |
||
SULT4A1
Target Class: Transferases Disease Areas: Metabolism, Drug metabolism and toxicology, Cancer Site: Toronto Status: Official |
||
HSD17B4A
Target Class: Oxidoreductases Disease Areas: Signalling, Neurobiology, Metabolism Site: Oxford Status: Official |
||
AK1A
Target Class: Non-protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
PY00382
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PY00104
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
ARF4
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
SPRA
Target Class: Oxidoreductases Disease Areas: Neurobiology, Metabolism, Drug metabolism and toxicology Site: Oxford Status: Official |
||
UBH14
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
PFI1420w
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
ARL5
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
CLK1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
GCN5L2
Target Class: Transferases Disease Areas: Signalling, Chromatin and epigenetics Site: Toronto Status: Official |
||
CENTG1A
Target Class: GTPases Disease Areas: Neurobiology, Cancer, Signalling Site: Oxford Status: Official |
||
GMPRA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
ARL8
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
PECRA
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism Site: Oxford Status: Official |
||
FDPSA
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer Site: Oxford Status: Official |
||
UBC53
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
FDPSA
Target Class: Transferases Disease Areas: Site: Oxford Status: Follow-up not counted |
||
UBH26
Target Class: Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
PFL0660w
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Signalling, Cancer Site: Oxford Status: Follow-up not counted |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
PTPN5A
Target Class: Phosphatases Disease Areas: Neurobiology, Signalling Site: Oxford Status: Official |
||
UBC45
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Neurobiology Site: Toronto Status: Official |
||
UBC40
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
UBC44
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
RETSDR3A
Target Class: Oxidoreductases Disease Areas: Cancer Site: Oxford Status: Official |
||
CRYZA
Target Class: Oxidoreductases Disease Areas: Drug metabolism and toxicology, Metabolism Site: Oxford Status: Official |
||
RETSDR2A
Target Class: Oxidoreductases Disease Areas: Metabolism, Signalling Site: Oxford Status: Official |
||
PF14_0417
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
UBC46
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
HSD11B1A
Target Class: Oxidoreductases Disease Areas: Signalling, Metabolism Site: Oxford Status: Official |
||
PIM1A
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
SULT1b1
Target Class: Transferases Disease Areas: Cancer, Drug metabolism and toxicology, Metabolism Site: Toronto Status: Official |
||
KIRBAC31A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up not counted |
||
MGC4172A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Official |
||
PY04285
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
PFE0545c
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
GMDSA
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Signalling Site: Oxford Status: Official |
||